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Abstract 
Bluetongue virus belongs to the Orbivirus genus from the Reoviridae family. It infects 
predominantly domestic and wild ruminants and is economically significant worldwide. Bluetongue 
virus VP7 forms the intercepting layer between the outer capsid (VP2 and VP5) and VP3 which 
surrounds the genomic material. BL21(DE3), NiCo21(DE3), C43(DE3) pLysS and KRX Escherichia coli 
cells were transformed with a pET28a plasmid with the cDNA sequence encoding Bluetongue virus 
VP7. Expression of Bluetongue virus VP7 was tested at post induction temperatures between 16˚C 
and 37 ˚C, at inducer concentrations between 0.1 mM and 1.0 mM isopropyl-β-D-
thiogalactopyranoside in BL21(DE3), NiCo21(DE3) and C43(DE3) pLysS cells and 0.05 % and 0.15 % 
rhamnose for KRX cells, in two types of growth media (LB and 2xYT) and post-induction growth 
times between two and 16 hours. Under all conditions tested; Bluetongue virus VP7 expression was 
found to be predominantly in the insoluble fraction (pellet). BL21(DE3) and NiCo21(DE3) cells were 
chosen and grown for five hours post induction, induced with 0.1 mM isopropyl-β-D-
thiogalactopyranoside and grown at a post-induction temperature of 37 ˚C. Bluetongue virus VP7 
in bacterial cell inclusion bodies was solubilised using urea and a freeze-thaw step. Solubilisation 
was tested with urea concentrations between 2 M and 8 M, with solubilisation efficiency not 
increasing past 5 M urea. Solubilized Bluetongue virus VP7 was purified using nickel-affinity 
chromatography. Purified Bluetongue virus VP7 was then probed with far-UV circular dichroism 
and intrinsic fluorescence in several buffer conditions including different urea and guanidinium 
chloride concentrations as well as in the presence of glycerol and sodium chloride. Guanidinium 
chloride was able to cause Bluetongue virus VP7 unfolding, and the unfolding transition had 94 % 
and 89 % reversibility at 218 nm and 222 nm respectively. Bluetongue virus VP7 was shown to 
contain a native-like structure in 20 % glycerol and in up to 8 M urea and was found to be stable till 
at least 55 ˚C, even in the presence of 5 M urea. Glycerol and sodium chloride influenced the 
conformation of the protein resulting in different unfolding transitions. Thermal unfolding of 
Bluetongue virus VP7 was found to be irreversible. 
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1. Introduction. 
1.1 Bluetongue virus.  
Bluetongue virus belongs to the genus Orbivirus from the family Reoviridae as indicated by Viral 
Zone, a viral database (Hulo et al., 2011). The family Reoviridae has twelve types of dsRNA viruses 
which are all multi-segmented, and infect a large range of hosts including insects, reptiles, fish, 
crustaceans, mammals (including Homo sapiens), plants and fungi (Howerth et al., 1988; 
MacLachlan, 1994; Mertens et al., 2004). Bluetongue virus is particularly important economically, 
not only because of livestock fatalities, but also the indirect loss due to banning the movement of 
livestock because of the potential spread of infection to susceptible areas (Alexander et al., 1996).  
Before the 1940’s Bluetongue virus was believed to occur only within Southern Africa, but in 1943 
the first comprehensively documented occurrence of Bluetongue virus outside of Africa occurred 
in Cyprus (Gambles, 1949). The reliance on the anthropoid vector at first meant Bluetongue virus 
occurred exclusively in the tropic and temperate areas (Gorman, 1990), but climate change has 
resulted in the midges migrating out of these areas (Mellor and Wittmann, 2002; Enserink, 2006). 
This has resulted in Bluetongue virus being present on every continent excluding Antarctica 
(MacLachlan et al., 2009). Periodically, pandemic outbreaks of Bluetongue virus, now commonly 
occur throughout the world (Patel and Roy, 2014). Outbreaks are seen to be seasonal, and mainly 
in areas that promote proliferation of the vector, such as a hot, humid climate, which also provides 
the required environment for larvae development (e.g. stagnant water and cattle dung) (Spreull, 
1905; Ward, 1994). 
The poorer and marginal farmers suffer from high mortality rates and many wool industries have 
been crippled due to outbreaks in susceptible areas (Pathak et al., 2008). Biosecurity is fundamental 
to the prevention of accidental spreading of the Bluetongue virus to vulnerable and susceptible 
areas (Waage and Mumford, 2008; Noad and Roy, 2009). Bluetongue virus affects many domestic 
and wild ruminants (Bekker et al., 1934; Howell, 1966). It has also been found in buffalo, camels, 
deer and other Artiodactyla (Erasmus, 1975; Howerth et al., 1988) and has even been found in 
some African carnivores (Alexander et al., 1994). 
One of the biggest challenges faced with Bluetongue virus is that it is not immunologically simple, 
as it has multiple serotypes. A serotype is a serologically distinguishable strain of a microorganism. 
That is, through examination of blood serum for antibodies the strains are distinguishable from one 
another as they elicit a different immune response.  
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Through the use of serum neutralization tests, 24 serotypes of Bluetongue virus have been known 
for decades (Huismans et al., 1987b) and subsequently a 25th (Chaignat et al., 2009), 26th (Maan 
et al., 2011) and 27th (Jenckel et al., 2015) serotype have been discovered. The great number of 
serotypes significantly complicates the ability to treat, diagnose and vaccinate animals against 
Bluetongue virus. Viral protein 2 (VP2) and viral protein 5 (VP5) are the greatest contributors to 
serotype determination as together they form the exposed surface of the virion (Huismans and 
Erasmus., 1981). 
1.2 Structure of Bluetongue virus. 
All Reoviridae viruses are dsRNA viruses that appear to have a similar capsid organization that is 
made up of more than one protein layer, each having a core that contains the viral genome (Hulo 
et al., 2011). The Bluetongue virion is 80nm in diameter with a distinctive structure of an outer and 
inner capsid (Verwoerd et al., 1972; Prasad et al., 1992; Grimes et al., 1998), which can be seen in 
Figure 1.1. The viral particle contains seven structural proteins named VP1 through 7, four non-
structural proteins named NS1 through 4 and 10 dsRNA molecules that are enclosed within the 
core (Verwoerd et al., 1972; Huismans, 1979). Viral proteins 1, 4 and 6 are considered minor 
proteins as they have a much lower concentration compared to the major viral proteins 2, 3, 5 and 
7 (Verwoerd et al., 1972). The inner capsid core is comprised of a lattice of VP7 trimers that coats 
a layer of VP3 monomers (Grimes et al., 1998) along with VP1, VP4 and VP6 (Figure 1.1). VP2 trimer 
spikes surrounding VP5 trimers (Figure 1.1) make up the outer capsid (Huismans and Erasmus, 
1981; Hyatt and Eaton, 1988; Zhang et al., 2016). 
VP2 has the highest sequence variability and is, therefore, the principal determinant of serotype 
antigens, and VP5 to a lesser degree is also involved in serotype determination (Huismans and 
Erasmus, 1981). VP7 is important structurally as it is the bridge between the VP2-VP5 capsid layer 
and VP3, which surrounds the genome. The core contains multiple solvent channels and the outer 
capsid has intrinsic instability and can easily be made to dissociate by proteolysis and mildly acidic 
conditions, a characteristic vital to viral replication as it allows core release which then activates 
the transcription machinery within the core to start replication of the viral RNA (Verwoerd et al., 
1972; Patel and Roy, 2014). 
VP2 is imperative to host cell attachment and VP5 has been found to be able to penetrate the host 
cell membrane (Huismans et al., 1987c; Hassan, 1999; Hassan et al., 2001; Forzan et al., 2007) which 
is vital for viral replication within the mammalian host.  
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Figure 1.1. Structure of Bluetongue virion. 
Diagrammatic representation of the structural organization of the viral proteins that construct the 
Bluetongue virion. Shown are proteins VP1 through 7. Figure constructed by the author based on 
information obtained from Verwoerd et al. (1972); Huismans (1979); Patel and Roy (2014). 
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1.3 Mode of infection and replication cycle of Bluetongue virus.  
Culicoides midges are responsible for the transmission of Bluetongue virus (Du Toit, 1944). Of over 
a thousand species of Culicoides, only a small percentage have been connected to contracting and 
transmitting Bluetongue virus (Mellor, 1990). It has been seen that even individual midges within 
a single species show a variation of susceptibility to infection (Jones and Foster, 1978).  
Culicoides midges become infected through ingestion of a viraemic blood meal when feeding (Du 
Toit, 1944). The female midges are responsible for Bluetongue virus transmission as they feed on 
blood meals, whereas, the male’s diet consists of only plant juices (Birley and Boorman, 1982). 
Specific molecular details of replication after attachment to Culicoides midge’s cells is unknown, 
however, more is known on the viral pathway through the midge from infection to transmission. 
Once ingested Bluetongue virus enters the mid-gut cells, infecting them and thus replicating within 
them (Megahed, 1956; Chamberlain and Sudia, 1961; Jennings and Mellor, 1988). Progeny viruses 
enter the haemocoel, which is the primary body cavity of most invertebrates that contains its 
circulatory fluid, via the basement lamina. From the haemocoel, secondary infection occurs (Bowne 
and Jones, 1966; Chandler et al., 1985).  
Secondary infection results in the virus replicating in other targeted tissues most significantly being 
the salivary glands. Once sufficient replication has occurred in the salivary glands, the infected 
midges can transmit the disease to susceptible animals. The cycle from infection of the midge to its 
ability to transmit the virus to the animals it feeds on is approximately 15 days and varies mainly 
due to temperature (Chandler et al., 1985; Mellor, 1990). Infected Culicoides midges predominantly 
remain infected for life (Mellor, 1990). Foster and Jones (1979) discovered a two-phase replication 
cycle with a large increase in viral titre occurring at three to four days, which they attributed to the 
progeny virus leaving the gut wall and a second large viral titre increase at 10 to14 days which they 
attributed to secondary target organ infection. The lag in viral titre before three days is presumably 
because of the viral attachment and penetration within the midge gut wall cells. 
Culicoides midge cells have been shown to become infected by full Bluetongue virions (VP2 and 
VP5 mediated pathway), by core particles that have had the outer capsid layer removed, and by 
ISVPs, which are infectious subviral particles that are produced by the digestion of full Bluetongue 
virions with chymotrypsin and trypsin (Mertens et al., 1987). With ISVPs showing the highest 
infectability (Mertens et al., 1987). For core particles and ISVPs, it appears that Bluetongue virus 
VP7 has the ability to attach and penetrate the Culicoides host cells (Xu et al., 1997; Tan et al., 
2001).  
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It has long since been believed that digestive enzymes in the midge gut could result in modification 
of the viral particle. The digestive enzyme profile of Culicoides midges themselves is unknown, but 
it has been discovered that many other groups of haematophagous insects secrete, into the gut, 
an assortment of proteases, most commonly including chymotrypsin and trypsin (Akov, 1972; 
Briegel and Lea, 1975). This is further supported by the RGD motif present in Bluetongue virus VP7 
forming the attachment to midge’s cells during infection (Tan et al., 2001).  
The Bluetongue virus replication cycle alternates between Culicoides midges and mammalian hosts. 
Bluetongue virus is non-contagious and cannot be transmitted by contact with or between animals 
(Hutcheon, 1902; Spreull, 1905). For mammalian hosts, Culicoides transfer the virus through their 
saliva while feeding, and thus the virus is able to enter the mammalian bloodstream (Du Toit, 1944; 
Barratt-Boyes and MacLachlan, 1994). In addition to transmission via midges, it has been seen that 
in certain specific serotypes, trans-placental transmission can occur with subsequent foetal 
infection (Gibbs et al., 1979). Studies have also shown that when the bull is viraemic, transmission 
of the virus can occur via its semen (Bowen and Howard, 1984; Howard et al., 1985). 
The primary infection after viral entry occurs mainly in endothelial cells and phagocytes, found 
within the lymph nodes close to the location where the Culicoides midge has fed (Barratt-Boyes 
and MacLachlan, 1994). Adhesion to the host cell is possible because VP2 has the ability to attach 
to the cell membrane’s glycoproteins (seen in Figure 1.2) (Huismans et al., 1987c; Mertens et al., 
1987; Hassan, 1999; Du et al., 2014). After attachment, internalization of the virus is facilitated by 
the host cell’s calthrin-mediated endocytosis machinery (Eaton and Crameri, 1989; Forzan et al., 
2007). VP5 pierces the host cell endosome and facilitates the delivery of the viral core into host 
cytosol (Huismans et al., 1987c; Mertens et al., 1987; Hassan, 1999; Hassan et al., 2001; Forzan et 
al., 2007; Du et al., 2014). The lower pH inside the endosome causes the release of VP2 first and 
then in the late endosome, the pH drops even lower which causes VP5 to bind and penetrate the 
endosome membrane and facilitate the core’s translocation into the cytoplasm (Forzan et al., 2007; 
Zhang et al., 2016).  
The genome is retained within the core which helps to prevent an innate immune response being 
activated (Mohl and Roy, 2014). The core holds all the essential components needed for 
transcription of the ten genome segments to produce ten viral single-stranded (positive sense) RNA 
molecules, which are then later extruded from the core (Van Dijk and Huismans, 1982). Host cell 
ribosomes then translate the RNA molecules, generating VP1 to VP7 and NS1 to NS4 (Mertens et 
al., 1984; Ratinier et al., 2011). Positive sense ssRNAs also acts as the template for negative sense 
ssRNA that together makes up the viral genome dsRNA (Verwoerd and Huismans, 1972).  
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Figure 1.2. Replication of Bluetongue virus. 
Represents Bluetongue virus replication following the steps of cell entry, replication, assembly and 
release. It utilizes inclusion bodies in order to assemble the proteins required to form its core, but 
the addition of the final viral protein layer occurs in the cytoplasm before viral maturation and 
release. Figure constructed by author based on information obtained from Van Dijk and Huismans 
(1982); Mertens et al. (1987a); Hyatt et al. (1989); Hassan (1999); Hassan et al. (2001); Wirblich et 
al. (2006); Forzan et al. (2007); Zhang et al. (2016).   
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Within viral inclusion bodies formed by NS2 in the host cell cytoplasm (Eaton et al., 1987; Kar et al., 
2007), the core particles are assembled. After core particles are excised from the viral inclusion 
bodies, VP2 and VP5 are attached, signifying the maturation of the viral particles (Kar et al., 2007). 
Complete Bluetongue virus particles then leave the host cell by two main methods, namely NS3 
mediated budding, which usually occurs in the early stages of viral infection, or by penetration 
through the host cell membrane, which causes irreparable damage to the host cell and results in 
the lysis (Hyatt et al., 1989; Wirblich et al., 2006). Lysis in Culicoides cells rarely occurs (Mellor, 
1990). Lysis of host cells during late stage replication of the virus results in many of the symptoms 
commonly seen in Bluetongue virus infection.  
1.4 Bluetongue virus symptoms and infection.  
Common signs and symptoms include depression, fever, nasal discharge and crusting, drooling 
saliva, facial oedema, an excess of blood in coronary bands and general muscle weakness which 
often leads to lameness (Spreull, 1905; Moulton, 1961; Erasmus, 1975). Common lesions of 
Bluetongue virus include haemorrhage and ulcers in the mouth and gastrointestinal tract, muscle 
atrophy (due to necrosis), oedema of the lungs as well as pericardial, pleural and abdominal 
discharge (Spreull, 1905; Moulton, 1961; MacLachlan et al., 2009). Laboured breathing is seen in 
animals where severe pulmonary oedema has occurred (Moulton, 1961; Erasmus, 1975). Animals 
that develop prolonged illness suffer acute muscle atrophy and weakness, fatigue, generalized 
oedema and torticollis (animals head permanently tilted to one side due to muscle spasms) 
(Erasmus, 1975; Verwoerd and Erasmus, 2004).  
The virus then enters the bloodstream causing primary viraemia and quickly spreads to secondary 
tissues (Barratt-Boyes and MacLachlan, 1994; Sanchez-Corden et al., 2010). The virus replicates 
most frequently in vascular endothelial cells, macrophages and lymphocytes (Barratt-Boyes and 
MacLachlan, 1994; MacLachlan et al., 2009; Drew et al., 2010a, Drew et al., 2010b). 
At the molecular level, the symptoms seen result from various processes within the animal’s body 
that are activated by the viral infection. One example is that during infection the p38 MAP kinase 
gets activated, which causes the permeability of the animal’s vascular system to increase (Chiang 
et al., 2006; Drew et al., 2010b). There is also an increased production of TNF alpha, IL-1, IL-8, IL-6, 
IFN-1, cylooxygenase-2, prostacyclin and thromboxane which are all responsible for the extreme 
inflammatory response (MacLachlan and Thompson, 1985; DeMaula et al., 2001). The excessive 
inflammatory response results in oedema and damage to tissue seen in a Bluetongue virus 
infection.  
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There is a four to eight day delay before symptoms appear and viraemia duration varies between 
species and even within different breeds within each species. It persists for 14 to 54 days in sheep 
(Koumbati et al., 1999), 19 to 54 days in goats (Barzilai and Tadmor, 1971) and 60 to 100 days in 
cattle (Sellers and Taylor, 1980). 
Bluetongue virus produces variable signs and symptoms in different species and breeds, with 
numerous species not showing any at all (Hutcheon, 1902; Spreull, 1905; Gard, 1984; MacLachlan, 
1994). Viraemia occurs in sheep, who generally develop the most severe symptoms. The disease is 
rarely symptomatic in cattle, goats or wild ruminants (Gard, 1984; Maclachlan, 1994). The ability of 
the virus to infect animals without causing them to become symptomatic creates the opportunity 
of the asymptomatic or less severely affected animals to provide a reservoir for the disease, which 
enables it to spread to more susceptible species and breeds while remaining undetected in the 
animals that do not show typical signs of infection (Hourrigan and Klingsporn, 1975).  
As there is currently no treatment for Bluetongue virus available, other than symptomatic 
treatment, there is an urgent need for effective vaccines and fast diagnosis of infected animals. (Li 
et al., 2009; Amin et al., 2016).  
1.5 Diagnosis and vaccines.  
Effective, reliable and fast diagnostic tools are very important in controlling Bluetongue virus. There 
are various serological and virological procedures for diagnosis. Serological methods include agar 
gel, immunodiffusion and competitive ELISA, whereas virological methods include virus isolation 
and reverse transcription polymerase chain reaction (RT-PCR) (Afshar et al., 1987; Drolet et al., 
1990; Vandenbussche et al., 2008). Several enzyme immunoassays have been created to distinguish 
between many Bluetongue virus serotype specific antibodies. The Bluetongue virus VP7 protein is 
the favourite for the development of group-specific serological assays because of it having a high 
sequence similarity between all serotypes (Kowalik and Li, 1991).  
Many different kinds of vaccines have been created for Bluetongue virus including antigen, 
inactivated and live attenuated viral vaccines (Alexander et al., 1951; Parker et al., 1975; Campbell, 
1985; Hunter and Modumo, 2001; Savini et al., 2008). There are however two major problems with 
the current vaccines in use. Firstly that it is not currently possible to distinguish between a 
vaccinated animal and an infected one, which is important for the ability to move livestock (DIVA-
Differentiating infected from vaccinated animals). Secondly, Bluetongue virus is not 
immunologically simple, as it exists in 27 serotypes that are distinct from each other and the 
vaccines given are serotype specific.  
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That is, they only provide immune protection against a specific serotype (Huismans et al., 1987b; 
Chaignat et al., 2009). VP2 and VP5 are the major antigenic proteins and inducers of the production 
of neutralizing antibodies (Huismans et al., 1987a). However, they are also highly variable 
(Huismans et al., 1987a; Iwata et al., 1992; Russell et al., 2018) and therefore the root cause of the 
lack of cross neutralization seen between serotypes. (Huismans and Erasmus, 1981; Appleton and 
Letchworth, 1983).  
To try overcome this a cocktail of attenuated virus strains is usually administered, but a vaccine 
containing all 27 serotypes is not commercially viable (Noad and Roy, 2009). There is also the issue 
that genome segment re-assortment between different serotypes can occur, so the more you 
increase the number of serotypes in each single vaccination, the greater the chance of generating 
novel progeny strain, for which there is no vaccine available (Cowley and Gorman, 1989; Mertens 
et al., 1984; Batten et al., 2008). The vaccine currently used in South Africa is an Onderstepoort 
Biological product, a live attenuated polyvalent vaccine that administers a cocktail of 15 serotypes 
over three doses in 9 weeks (Dungu et al., 2004; Coetzee et al., 2012). 
Several of the problems that have been encountered with the currently available vaccines are 
thought to be able to be overcome by the development of protein-based vaccines (Huismans et al., 
1987b; Roy, 1990; Roy et al., 1992; Stewart et al., 2013; Thuenemann et al., 2013). Promising 
protein-based vaccines include subunit vaccines (Huismans et al., 1987b) that contain either 
solitary proteins or combinations of proteins. However, subunit vaccines have proved to be 
expensive to develop. One of the most promising approaches for future vaccines is the production 
of a composite of VP2, VP5, VP7 and VP3 into a virus-like particle (Roy, 1990), which contains no 
virus nucleic acids, so is, therefore, able to initiate a similar immune response but is unable to 
replicate. This allows for vaccinated animals to be distinguishable from infected animals, as animals 
that have received the vaccine will not display the viral nucleic acids (French et al., 1990; Loudon 
et al., 1991; Roy et al., 1992).  
The main aim of a vaccine is to induce the same long lasting level of protection that infection would 
incur without suffering from the actual disease. Studies have shown that Bluetongue virus VP7 is 
able to induce an antibody response that is at least partially protective, suggesting that sections of 
VP7 are accessible on the viral surface (Lewis and Grubman, 1990; Martin et al., 2015). Bluetongue 
virus VP7 is recognised to induce a T-cell immune response, namely, it is able to activate CD8+ and 
CD4+ cells (Kowalik and Li, 1991; Rojas et al., 2011). Bluetongue virus VP7 is also the major 
serogroup-reactive antigen (Huismans and Erasmus, 1981; Gumm and Newman, 1982) and 
therefore, is an excellent candidate for cross-serotype protection.  
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This is significant as VP5 and VP2 are known to induce a B cell immune response and therefore by 
combining a mixture of recombinant viral proteins within a vaccine you are potentially activating 
both B cell and T cell immune responses, which are known to provide stronger and longer lasting 
immune protection than vaccinations that just activate the B cells (Brooks et al., 2016; Linterman 
and Hill, 2016). 
1.6 The Bluetongue virus VP7 protein. 
Bluetongue virus VP7 is encoded by Bluetongue virus genome segment seven and contains 349 
amino acids, which is 1154-1156 base pairs (Caspar et al., 1962; Pathak et al., 2008). Bluetongue 
virus VP7 has a reported molecular mass of 38 kDa (Basak et al., 1992; Grimes et al., 1995) and 
contains 9 tyrosine (Tyr), 5 tryptophan (Trp) and 14 phenylalanine (Phe) amino acids (Grimes et al., 
1995; Gasteiger et al., 2005; Russell et al., 2018). The VP7 trimer has a length of 85Å and a width 
of 65Å (Grimes et al., 1995). As seen in Figure 1.3, a monomeric subunit contains two distinct 
domains. One domain is smaller as it is composed of approximately one-third of the polypeptide 
residues (residues 121 to 149) and forms a beta-sheet. The second domain is bigger and consists of 
the residues 1 to 120 and 250 to 349 and forms alpha-helices that contain long extending loops 
(Grimes et al., 1995).  
The domains are twisted around a 3-fold axis so one monomer’s alpha-helical domain lines up with 
the beta-sheet domain of a neighbouring subunit as seen in Figure 1.3 (Grimes et al., 1995). Each 
viral particle contains 780 replicates of the VP7 protein, which arranges into 260 trimers with a 
T=13 quasi-equivalent lattice (Caspar et al., 1962; Grimes et al., 1997). The Bluetongue virus VP7 
used for structural determination by Grimes et al. (1995) was expressed using a baculovirus system, 
based on methods described by Oldfield et al. (1990) who used Spodoptera frugiperda cells which 
were transfected with pAcYM1 baculovirus transfer vector containing the Bluetongue virus VP7 
gene sequence. Infected Spodoptera frugiperda cells were grown in monolayers at 28˚C for 3 days, 
before extraction and purification using Q-Sepharose column and sodium chloride as the eluting 
agent (Basak et al., 1992). Expression of recombinant proteins in a baculovirus system is a common 
method, but the culture of insects that is required is expensive and difficult to work with, it is, 
therefore, a lot cheaper and easier to work with prokaryotic systems (Marino, 1989; Dater et al., 
1993). 
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Figure 1.3. Bluetongue virus VP7 structure. 
Diagram showing Bluetongue virus VP7 monomer and trimer conformations. The two domains 
found in a VP7 molecule are labelled beta-sandwich and alpha-helical respectfully. The surfaces in 
contact with the other protein layers found within a Bluetongue viral particle are also labelled. 
Trimer with surface covering is shown to indicate how the domains from monomer subunits interact. 
The structure was acquired from the protein data bank (1BVP) and viewed with PyMOL Molecular 
Graphics System (1.3rl Edu), Schrödinger, LLC.  
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1.7 Bacterial protein expression systems and inclusion body formation. 
Recombinant proteins have been expressed in various systems including mammalian, insect, yeast, 
plant, bacterial and in vitro translation systems (Itakura et al., 1977; Hitzeman et al., 1981; Wirth 
et al., 1988; Marino, 1989). One of the most common prokaryotes used as an expression system is 
Escherichia coli (Marino, 1989; Terpe, 2006).  
The advantage of Escherichia coli is its ability to produce large quantities of the desired protein for 
a low price (Datar et al., 1993), as Escherichia coli cultures do not require very strict sterile 
conditions, expensive media and extensive growth maintenance like mammalian and insect cells 
(Verwoerd et al., 1979; Marston, 1986; Marino, 1989; Martyn et al., 1991). The Escherichia coli cells 
also have a much faster growth rate than mammalian cells and therefore this shortens the total 
time needed for an expressed protein to be utilised (Marino, 1989). 
Escherichia coli importantly possesses inducible promoters, prokaryotic ribosome binding sites 
(with initiation codon and Shine-Dalgarno sequence) and a transcription terminator, which all help 
make translation and transcription of the desired protein possible (Itakura et al., 1977; Marino, 
1989; Makrides, 1996). 
Plasmids are commonly found in bacterial cells and consist of small double-stranded circular DNA 
molecules that are naturally taken up by bacteria, often allowing them to incur antibiotic resistance 
as the plasmids frequently hold genes for antibiotic resistance (Lederberg, 1952; Stanisich, 1988; 
Gogarten and Townsend, 2005). Plasmids replicate independently of the host genome and can 
transfer genes horizontally (Gogarten and Townsend, 2005). The plasmid can be genetically 
modified to contain a foreign gene insert that is then expressed by the bacteria transcription and 
translation machinery when induced. This is achieved by cutting the plasmid at specific restriction 
sites, which results in single-stranded overhangs which are then duplicated on the gene insert so 
that the gene insert can bind to the plasmid. The plasmid DNA contains a promoter, which is 
upstream of the target gene, and repressor that binds the operator and prevents the expression of 
RNA polymerase until the addition of an inducer. When the plasmid is induced the repressor is 
removed allowing RNA polymerase to be expressed, resulting in expression of the desired gene. 
Finally, the plasmid contains a gene that gives it resistance to an antibiotic which is important as 
this acts a selectable marker. 
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Expression in bacterial cells has two main disadvantages, firstly that they are unable to perform as 
extensive posttranslational modifications as eukaryotic cells which can be critical for correct 
production of certain proteins and secondly, in bacterial cells recombinant proteins are frequently 
overexpressed in insoluble inclusion bodies (Marston, 1986; Hockney, 1994; Makrides, 1996). 
However, inclusion bodies are able to form in mammalian, yeast and insect cells (Palmer and 
Wingfield, 2004). Studies into inclusion body formation in bacterial cells found that the aggregation 
of the expressed protein is strongly dependent on expression conditions, including temperature, 
inducer concentration, post induction growth time and bacterial cell line (Hockney, 1994; Makrides, 
1996; Calamai et al., 2005; Terpe, 2006). 
Despite extensive studies little is understood about inclusion body structure or formation 
(Villaverde and Carrio, 2003). Regulatory mechanisms in the crowded cellular environment try to 
balance a number of different processes for peptides and proteins including folding, prevention of 
aggregation, protein transport and proteolysis (Dobson, 2003). Several studies suggest that 
aggregation of protein occurs from protein folding intermediates produced in the process of folding 
(Gupta et al., 1998; Smith and Hall, 2001). This follows the thought that the process of protein 
aggregation is reliant on the primary sequence of the expressed protein and the physiological and 
chemical interactions the sequence creates (Chiti et al., 2003; Dubay et al., 2004).  
Also important is the phenomenon of protein macromolecular crowding in Escherichia coli’s 
cytoplasm, which increases the likelihood of incorrect protein folding and often occurs in long post 
induction growth times and high inducer concentrations and temperatures (Van den Berg et al., 
1999; Van den Berg et al., 2000). 
The metabolic burden on bacterial cells also plays a significant role in inclusion body formation. 
Metabolic burden is the use of host cell’s energy and raw materials for the transcription and 
translation of foreign DNA into protein, and it is often linked to causing a stress response in the 
cells, which causes a serious disruption in host cell metabolism (Bentley and Kompala, 1990; 
Rahmen et al., 2015). Maintenance of a plasmid often places strain on bacterial cells, particularly 
when the foreign protein is greatly expressed (Bailey, 1993; Hoffmann and Rinas, 2004). 
The appearance of numerous target proteins in bacterial inclusion bodies resulted in research being 
conducted into the utilization of protein found in the inclusion bodies by solubilisation of the 
protein and subsequent retention of native protein or the refolding into active native protein 
(Przybycien et al., 1994; Jevsevar et al., 2005; Umetsu et al., 2005; Ami et al., 2006; Doglia et al., 
2008). 
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1.8 Solubilisation of recombinant protein expressed in insoluble bacterial 
inclusion bodies. 
Although the exact structural formation of inclusion bodies is not yet known they are said to be 
made up of a sponge-like organization containing structural amyloid-like fibres and a protein filled 
matrix (Carrio et al., 2005; Morell, 2008; Wang, 2009; Walther et al., 2013). Little is understood 
about inclusion body structure or the process of solubilisation, however, Walther et al. (2013) 
discovered that the inclusion body size shrinks during solubilisation and pore-like structures appear 
in the structural inclusion body, through which the proteins diffuse out of and become soluble.  
Therefore, the difference seen in the degree of solubilisation of protein from inclusion bodies with 
different solubilisation methods is directly linked to the methods ability to create these pores in 
the inclusion body structure. The effectiveness of protein solubilisation is also said to be dependent 
on the concentration of solubilizing agents, pressure, temperature, and the level of dissolved 
oxygen during the experiment (Walther et al., 2013).  
Solubilisation can occur through various methods including using detergents (Puri et al., 1992; 
Kurucz et al., 1995), arginine (Tsumoto et al., 2004; Umetsu et al., 2005) as well as extreme pH 
values (Iwakura et al., 1992) but most commonly, a high concentration of denaturants or strong 
ionic detergents is used (Tsumoto et al., 2003).  
However, this has a disadvantage, as the high denaturant concentrations have been known to 
cause permanent structural damage to the proteins found within the inclusion body. Therefore, it 
is more advantageous to use milder solubilisation conditions that disrupt the inclusion body 
structure but not the protein structure within (Kurucz et al., 1995; Tsumoto et al., 2004). That being 
said, the solubilisation of each individual protein is said to be unique as it has been found that the 
recombinant protein itself, as well as the expression conditions, influence the inclusion bodies 
structure and porosity (Margreiter et al., 2008). 
Some advantages to using proteins found in inclusion bodies include the fact that there are less 
other bacterial cell proteins in comparison to the proteins that have been expressed in the soluble 
fraction in a cell. Other proteins present in inclusion bodies are largely just proteins from the 
bacterial cell wall, meaning that the proteins found in inclusion bodies are more likely to be 
protected from proteolytic degradation. The inclusion bodies help guard the cell against the 
potential toxicity of the recombinant protein. The lower amount of bacterial cell protein expression 
found in inclusion bodies in comparison to the soluble fraction helps simplify further purification 
steps. 
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1.9 Purification of recombinant proteins using liquid chromatographic techniques. 
Using liquid chromatography to purify recombinant protein exploits characteristics that the target 
protein contains to separate it from a mixture of proteins. Chromatography generally consists of a 
fixed matrix with which the proteins interact, and different buffers that cause the desired 
interaction. Three of the most common chromatography techniques are affinity, size exclusion and 
ion-exchange. Affinity chromatography bases separation of proteins on the specificity of 
interactions between a ligand and receptor. Commonly a “tag” is added to a protein that allows it 
to bind specifically to a matrix. Frequently used tags include histidine residues, glutathione S-
transferase (GST) and S peptide (Kimple et al., 2015).  
Size exclusion chromatography exploits the different sizes of proteins within a mixture and is 
influenced by the proteins molecular mass, with heavier molecules eluting first and lighter ones 
eluting last as smaller proteins are able to interact to a greater extent with the pores that the matrix 
contains, due to their smaller size (Lathe, 1956; Porath and Flodin, 1959; Hjerten, 1964). Ion-
exchange exploits the ability of a protein to be either negatively or positively charged depending 
on the pH of the buffer it is in (Eckweiler et al., 1921; Giddings, 1965). For this study, two forms of 
liquid chromatography are important, namely ion-exchange chromatography and affinity 
chromatography.  
1.9.1 Ion-exchange chromatography. 
Ion-exchange chromatography utilises the ability of oppositely charged molecules to be attracted 
to one another (Adams and Holmes, 1935, Myers et al., 1941; Boyd et al., 1947; Peterson and Sober, 
1956; Chang et al., 1976) and the reversible reaction that can occur between charged molecules 
and an oppositely charged matrix (Adams and Holmes, 1935) and consists of a mobile and 
stationary phase. In terms of protein purification, the mobile phase is the mixture of molecules and 
the stationary phase is the fixed insoluble matrix within the resin that contains charged groups 
(Giddings, 1965). 
Proteins are amphoteric, that is they can react with either a base or an acid as they can either 
receive or donate hydrogen ions (Eckweiler et al., 1921). This is predominantly due to the presence 
of an N-terminal amine group, a C-terminal carboxyl group and ionisable side chain groups of amino 
acid residues, which creates the ability to manipulate the protein’s net surface charge by 
manipulating the pH and ionic strength of the buffer it is in, creating either a positive, negative or 
no net charge on the protein’s surface. The isoelectric point (pI) for a protein is the pH value where 
the protein doesn’t contain a charge, therefore the pI is also the isoionic point (Lampson and Tytell, 
1965).  
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At a pH greater than its pI, a protein will reversibly bind a resin carrying a positive charge and at a 
pH less than its pI, the protein will reversibly bind a resin carrying a negative charge (Lampson and 
Tytell, 1965). A protein’s net surface charge is dependent on the protein’s composition, as each 
protein is made up of a different combination of amino acids. The theory is that the protein will 
obtain a unique charge, as well as charge distribution and will, therefore, be eluted separately 
during purification when conditions on the column for binding and elution are changed (Tanford, 
1961; Tanford, 1962; Himmelhoch, 1971). 
Bound proteins are eluted off the column by either a change in pH or an increase in ionic strength. 
(Karlsson et al., 1998). For pH elution the net charge of the molecule changes as the pH of the buffer 
does, causing it to lose the net charge that is creating its ability to bind to the column, thus causing 
its elution off the column. An ionic strength elution is commonly achieved with the use of sodium 
chloride. When sodium chloride is added the sodium and chloride ions compete with bound 
molecules for the charges on the surface of the medium (Karlsson et al., 1998). Proteins with lower 
net charge are eluted first as the ionic strength begins to increase and proteins with higher net 
charge require higher ionic strengths in order to be eluted. Ion-exchange chromatography is 
popular as it has a large application base, a high resolving power, high binding capacity, is easy to 
manipulate to conditions required and has a relatively low cost. 
1.9.2 Immobilized metal affinity chromatography. 
Immobilized metal affinity chromatography (IMAC) is an affinity method presented in 1975 by 
Porath et al. (1975). IMAC utilizes the ability to fuse a protein to small molecules linked to a solid 
support (Hochuli et al., 1987). It is a form of protein purification that exploits specific binding 
between molecules. A specific ligand is coupled with a support molecule within a resin so that a 
mixture of proteins can be filtered through and those with the ligand affinity bind the resin. The 
non-affinity molecules in the original sample can then be washed off and the bound molecule can 
be isolated. The molecules with ligand affinity are then eluted from the column by reversing the 
binding by changing the conditions within the column and thereby purifying it out of its original 
sample. Ligand affinity is often added to the protein by the addition of an affinity tag, which is a 
sequence that has a binding affinity to the IMAC resin. Polyhistidine is the most frequently used tag 
(Yip et al., 1989). 
The amino acid histidine is capable of forming complexes with the nickel (Ni2+), and additional 
histidines increase the protein’s affinity for it (Yip et al., 1989; Hutchens and Yip, 1990). Histidine 
interacts strongly with immobilized metal ions due to the histidine having imidazole rings that have 
the ability to donate electrons which readily form bonds with the immobilized transition metals. 
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Application of affinity tag purification allows for the execution of general purification protocol for 
all tagged proteins as the purification is not dependent on the protein’s properties, such as size and 
charge, which creates extra testing work for other chromatography methods. That being said it is 
vulnerable to different behaviours of proteins such as aggregation and correct protein folding, 
hiding the tag and preventing binding (Lichty et al., 2005). 
Affinity tag chromatography, and specifically polyhistidine tagged purification, has several 
advantages including the ease at which the tag can be added in the vector to the protein, the high 
expression of the tagged protein, little need for removal of the tag as its small size enables the 
protein to stay functional and the mild elution conditions help preserve the protein’s natural 
structure and function (Crowe, 1994; Terpe, 2003; Lichty et al., 2005).  
The efficacy of purification of proteins containing a polyhistidine tag was increased by the invention 
of nickel-nitrilotriacetic acid (Ni2+-NTA) matrices (Hochuli et al., 1987). Nickel-nitrilotriacetic acid 
(Ni2+-NTA) and CO2+-carboxymethylaspartate are matrices that chelate the transition metals via 
four different coordination sites, whilst still allowing for two of the transition metals coordination 
sites to be free to interact reversibly with histidine residues. This results in a more stable matrix 
and therefore higher elution product purity (Hochuli et al., 1987; Chaga et al., 1999) in comparison 
to iminodiacetic acid (IDA), a matrix that chelates the transition metals through three different 
coordination sites (Porath et al., 1975). This, however, results in a loosely bound metal ion and 
therefore a greater amount of metal leaching during purification.  
Histidine-tagged affinity chromatography is among the most cost effective affinity tag purifications 
possible, taking into account resin, buffers and elution methods (Lichty et al., 2005). Although 
histidine residues occur reasonably seldom, cellular proteins do occasionally contain enough 
adjacent histidine residues to enable them to bind the IMAC matrix and be co-eluted with the target 
protein, decreasing the purity of the purification product (Schmitt et al., 1993). However bacterial 
cells contain fewer proteins than mammalian cells that contain histidines, and therefore 
purification using nickel affinity resin is easier using bacterial cells rather than mammalian cells 
(Bornhorst and Falke, 2000). 
1.10 Previous expression and purification of Bluetongue virus VP7. 
Expression of Bluetongue virus VP7 has been possible in multiple different systems including 
bacterial (Wang et al., 1994), yeast (Martyn et al., 1991), mammalian (Marin-Lopez and Ortego, 
2016) and insectoid systems (Oldfield et al., 1990). Some of the significant studies that have 
expressed Bluetongue virus VP7 include two studies that used insect cells infected by genetically 
modified baculovirus namely Oldfield et al. (1990) who used DEAE-Sephacel purification. 
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Bluetongue virus VP7 eluted off at 200 mM sodium chloride in a 10 mM Tris-HCl buffer, pH 7.5 and 
a yield of 100 mg/litre of cell culture of soluble Bluetongue virus VP7 protein was reported and 
Hosamani et al. (2011) who purified with histidine-tagged purification using a ProBond purification 
system (Invitrogen), which uses a sodium phosphate buffer with sodium chloride at pH 8 and 
obtaining 1.87 mg/7x106 cells of protein in four days. 
Also significant, French and Roy (1990) expressed core-like particles (VP7 and VP3) in insect cells 
using baculovirus infection and achieved a yield of 30 mg/litre of cells (1.5 x 109 cells) after lysing 
cells and purification using a discontinuous sucrose gradient. Core-like particles are formed when 
VP3 and VP7 are expressed together in an expression system and the proteins naturally form the 
viral core particle scaffolding without the presence of the genomic dsRNA or other viral proteins.  
High-level expression of soluble protein in bacterial cells has been challenging as high expression 
often leads to the protein being found predominantly in insoluble inclusion bodies (Verwoerd et 
al., 1979, Marston, 1986; Martyn et al., 1991; Wang et al., 1994). Wu et al. (2015) used BL21(DE3) 
Escherichia coli cells and reported a yield of 0.8 mg/ml and 1.0 mg/ml of insoluble Bluetongue virus 
VP7 after gel cutting and GST tagged purification respectfully. Other studies that have expressed 
Bluetongue virus VP7 in bacterial cells include Wang et al. (1994) who obtained insoluble protein 
and purified using preparative SDS-PAGE as defined by Hager and Burgess (1980) and Sudheerbabu 
et al. (2016) that expressed only the upper domain of Bluetongue virus VP7, also in the insoluble 
fraction, and purified using a chloroform wash. Pathak et al. (2008) expressed truncated 
Bluetongue virus VP7 in prokaryotic cells (Escherichia coli BL21) and purified using histidine-tagged 
affinity chromatography, with a sodium phosphate buffer containing urea and sodium chloride at 
a pH of 7.8, and eluted with imidazole.  
Martyn et al. (1991) used in vitro transcription/translation system and a yeast expression system, 
using sonication to extract Bluetongue virus VP7 from yeast cells. Finally, Bouet-Cararo et al. (2014) 
used mammalian hamster ovary cells (CHO-CAR) but no further expression details were given. 
Protein expression in insect and mammalian cells have not been able to consistently produce high 
quantities of soluble protein, and bacterial cells have consistently produced predominantly 
insoluble protein.  
The main focus of previous expression and purification protocols for Bluetongue virus VP7 has been 
the characterisation of the purified protein’s antigenicity and construction of viral-like particles 
(French and Roy, 1990; Oldfield et al., 1990; Wang et al., 1994; Pathak et al., 2008; Bouet-Cararo 
et al., 2014; Wu et al., 2015).  
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1.11 Spectroscopic determination of protein characteristics. 
Spectroscopy works on the principle that every molecule absorbs, transmits or reflects light 
(electromagnetic radiation) over a particular wavelength range. Absorbance spectroscopy studies 
the relationship between particles and electromagnetic radiation. Therefore, a spectrophotometer 
measures the number of photons that are absorbed as the light passes through a given sample 
solution. The absorption of light is measured as a function of its wavelength (Lakowicz, 1999).  
The peptide groups of the protein main chains and aromatic side chains of tyrosine, tryptophan 
and phenylalanine absorb light in the far-UV range (wavelengths between 180–230 nm) but the 
aromatic side chains also absorb light in the near-UV range which contained wavelengths between 
240–300 nm. Disulfide bonds (between two cysteine residues) also show an absorbance reading 
near a wavelength of 260 nm. The maxima of protein absorption is found between 275 nm and 280 
nm and is produced predominantly by tryptophan and tyrosine. The absorbance of phenylalanine 
and cysteine disulfide bonds also contribute to the reading in this wavelength range, but only to a 
very small extent (Schmid, 2001).  
The secondary structure of a protein defines the localized polypeptide chain fold that results from 
hydrogen bonds and it includes characteristic structures such as alpha-helices and beta-strands or 
sheets. A protein’s secondary structure can be determined by producing a far-UV circular dichroism 
spectrum for the protein of interest. Circular dichroism (CD) is able to quantify the variance 
between absorption coefficients for left and right circulatory polarized light of molecules that 
contain one or more light-absorbing groups known as chiral chromophores (Ranjbar and Gill, 2009). 
The spectrum produced by a protein is caused by absorption by disulfide groups, aromatic side 
chains, and the peptide backbone (Woody, 1995). Circular dichroism is measured over a range of 
wavelengths and is used to deduce the protein’s secondary and tertiary structure as well as protein 
conformational changes due to environmental variables (Ranjbar and Gill, 2009). 
In the far-UV region (180-250 nm) the signal is principally produced by the peptide backbone. 
Distinct CD spectra are a result of the peptide backbone adopting various secondary structures 
(Woody, 1995). Therefore, the shape of the curve produced by this wavelength range produces a 
description of the protein’s secondary structure.  
The maxima positive and negative points are especially important as they provide information 
about the specific protein being studied (Ranjbar and Gill, 2009). Proteins that contain alpha-helices 
display troughs at 208 nm and 222 nm, and a more positive peak near 190 nm, on the other hand, 
beta-strands display a characteristic minima at 218 nm and a positive band at 196 nm and random 
coils display a positive band at 212 nm and a minima at 195 nm (Ranjbar and Gill, 2009). 
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Absorption in the far-UV region (180-250 nm) is particularly vulnerable to interference from other 
components such as the buffer, solvents and reagents (Kelly and Price, 2000). Phosphate, borate 
and Tris are safe buffers to use, but even they should be kept to low concentrations. Chloride ions 
absorb strongly below 195 nm, and therefore should be kept to a minimum in buffers, instead, 
fluoride and sulfate can be used to maintain ionic strength (Kelly and Price, 2000). 
The tertiary structure of a protein defines the three-dimensional folding of the polypeptide and can 
be probed using fluorescence. The tertiary structure is held in its specific formation by electrostatic 
attractions between oppositely charged ionic groups, by weak van der Waal forces, by hydrogen 
bonds and by hydrophobic interactions. In certain proteins, disulfide bridges are essential for the 
tertiary structure formation.  
Fluorescence studies a protein’s tertiary structure by using the energy emitted from light in the 
electromagnetic spectrum to excite electrons from ground state to an excited state (Schmid, 2001). 
Fluorescence is, therefore, the emission that results from an electron returning from its excited 
state to its ground state (Lakowicz, 1999). The energy loss that occurs between excitation and 
emission causes a shift in the spectrum into the longer wavelengths, which is known as 
bathochromic (red) shift of the emission spectra and is due to a phenomenon called Stokes’ Shift 
(Lakowicz, 1999). In proteins, the intrinsic (naturally occurring) fluorophores are the aromatic 
amino acids tryptophan, tyrosine and phenylalanine. The fluorescence produced by most proteins 
is mainly the result of tryptophan, this is because native tyrosine and phenylalanine emission is 
transferred to tryptophan (Lakowicz, 1999).  
Tryptophan (Trp) fluorescence can be selectively excited at 295 nm, which avoids excitation of 
tyrosine. Hydrophobic environments (where Trp is concealed within the centre of the protein), 
results in Trp having a high quantum yield and therefore a high fluorescence intensity and a λmax 
around 335 nm (Lakowicz, 1999). Hydrophilic environments (where Trp is exposed to the aqueous 
solution surrounding the protein) results in the quantum yield declining and therefore a decrease 
in fluorescence intensity and a λmax around 355 nm.  
Therefore, it can be seen that for Trp residues, there is strong Stokes’ Shift which varies depending 
on the solvent present, meaning that the maximum emission wavelength and fluorescence 
intensity of a Trp molecule will fluctuate depending on the environment it is in (Lakowicz, 1999). 
Fluorescence is a valuable probe as it is robust, highly sensitive and non-invasive (Ladokhin et al., 
2000). The high sensitivity of intrinsic fluorescence allows for micro-molar concentration of protein 
to be used, minimizing the sample used (Eftink, 1994).  
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Tryptophan residues are a valuable intrinsic probe as most proteins contain very few of them, and 
the indole ring they contain is sensitive to their environment (Eftink, 1994). Spectroscopic analysis 
of proteins can also be valuable to study changes in protein structure in different environments 
including buffer conditions, denaturant concentration and changes in temperature. 
1.12 Thermodynamic protein stability studies.  
The main contributors to protein stability are the hydrogen bonds that form the secondary, tertiary 
and quaternary structures, as well as, van der Walls forces, hydrophobic interactions and disulfide 
bridges that contribute to the tertiary and quaternary structure and lastly, the protein’s interaction 
with its solvent environment (Kauzmann, 1959). In order to denature a protein, which means to 
unfold or deactivate a protein, these bonds and interactions need to be disrupted. The Gibbs free 
energy of a molecule is the usable energy of said molecule and is responsible for the spontaneity 
of the reactions possible by the molecule.  
The Gibbs free energy (ΔG) difference between the folded state (GF) and unfolded state (GU) can 
be used to express the thermodynamic stability of a protein. Gibbs free energy of a molecule is 
influenced by the enthalpy and entropy of the system. The enthalpy is the internal energy of a 
system, and entropy is a measure of disorder within a system. Change in Gibbs free energy is 
calculated by subtracting the product of the change in entropy and temperature (TΔS) from the 
change in enthalpy (ΔH). When ΔG is negative the reaction is said to be spontaneous. When the 
protein is folded the entropy of the system is low as the protein structure allows only a few 
conformations for the protein to move in. The enthalpy of the system is however also low, but 
proteins spontaneously fold into their lowest energy form and therefore the folded state is more 
favourable, that being said, the folded state of a protein is only marginally more stable than the 
fully unfolded state (Privalov, 1979).  
Thermodynamic reactions can also be seen in terms of an equilibrium reaction. The equilibrium 
constant (K) of said reaction is, therefore, the amount of product, in our case unfolded protein, 
divided by the amount of reagent, in our case folded protein. When the equilibrium constant (K) is 
greater than one, the product reaction is favoured, in other words, the unfolding reaction is 
favoured, if the equilibrium constant (K) is less than one the reagent is favoured, in this case, the 
folded protein. 
When the temperature is increased, the entropy of the system increases, making ΔG more negative 
and therefore favouring the unfolding of the protein as GU is greater than GF. Enthalpy is also 
temperature dependent and increases with an increase in temperature, but to a lesser extent then 
entropy (Schellman, 1987).  
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Chemical denaturants similarly cause disruption to the bonds and interactions that maintain 
secondary, tertiary and quaternary structures as well as the protein’s interactions with their 
environments (Timasheff, 1993). Therefore chemical denaturants are also able to increase the 
entropy of the system, favouring the unfolding reaction. 
Protein unfolding can either be reversible or irreversible, with the reversible reaction having the 
equilibrium constant (K) balancing the unfolded and folded protein percentages. Irreversible 
reactions have an unfolding rate constant that results in the formation of a final form, which is then 
unable to refold back to native form. Common causes of the irreversible unfolding of proteins 
include aggregation, autolysis and chemical alteration of residues (Privalov, 1982; Ahern and 
Klibanov, 1987). In order to obtain the parameters that are required to determine the function of 
protein stability, the protein unfolding has to be fully reversible, which is often not the case in 
thermal unfolding (Privalov, 1979). 
Two common techniques used in the analyses of protein thermodynamics are spectral techniques 
and differential scanning calorimetry (DSC). Fluorescence and circular dichroism can monitor 
alterations in secondary and tertiary structure whereas DSC measures the difference in heat 
capacity between a protein sample and a reference sample.  
For spectroscopic analysis of protein stability the peptide backbone and the aromatic amino acids 
Phe, Tyr and Trp (protein chromophores) are used to probe protein structural changes. 
Thermodynamic stability of a protein can be evaluated by consistently increasing the temperature 
of a protein sample and monitoring changes in protein structure using spectroscopy. The 
spectroscopic techniques of circular dichroism and fluorescence have been described in detail in 
section 1.11. However, notably, as tryptophan fluorescence signals (including signal intensity, 
emission maximum, quantum yield, fluorescence anisotropy and rotational correlation time to 
name a few) are subject to change depending on the protein's environment. This allows these 
parameters to assist in monitoring structural changes, including unfolding (Eftink and Ghiron, 1981; 
Gryczynski et al., 1988a; Eftink, 1994). However, it must be noted that a temperature dependent 
relationship is seen with the quantum yield of the indole chromophore. This phenomenon known 
as thermal quenching has been seen to occur in intrinsic tryptophan fluorescence which can result 
in a decrease in fluorescence intensity (quantum yield) with an increase in temperature without 
structural changes occurring (Demchenko, 1986). Similarly, circular dichroism spectra give details 
of the protein’s structure and therefore is able to monitor structural changes caused by changes in 
the protein’s environment (Righetti and Verzola, 2001). 
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On the other hand differential scanning calorimetry measures thermal events that occur in a 
protein that is being heated. Differential scanning calorimetry (DSC) directly measures the 
transition energy of the sample analysed (Watson et al., 1964). This is done by measuring the 
difference in energy needed to increase the temperature of a protein and a reference sample by 
the same amount. DSC can, therefore, monitor thermal events that accompany protein unfolding 
by measuring the energy released or absorbed.  
Enthalpy of denaturation can be determined from DSC experimental data. DSC measures the excess 
heat capacity at a constant pressure (Cpex) of a protein in relation to a reference sample as a 
function of temperature. The protein stability function (ΔG(T)) is determined using the melting 
temperature, (Tm), enthalpy, (ΔH(Tm)) and heat capacity increment (ΔCp) (Privalov, 1979). 
The unfolding of a protein is an endothermic event, due to the hydration of side chains that are 
concealed in the protein’s hydrophobic core, that become exposed to the hydrophilic solvent upon 
denaturation (Privalow, 1980; Sturtevant, 1987; Bruylants et al., 2005). Thus a greater amount of 
energy is needed to heat the protein sample compared to the reference sample and this additional 
energy is additional heat capacity above the normal heat capacity of the protein (Privalov, 1980; 
Atkins and de Paula, 2006). 
The denaturation of a protein appears as a peak in a DSC thermo analytical curve, the top of the 
peak, where the excess heat capacity is maximal, is the transition midpoint Tm. The integral of the 
area under the denaturation peak is the enthalpy of denaturation (ΔHm), which reflects the amount 
of secondary structure the protein contains (Watson et al., 1964; Tanford, 1970; Privalov, 1980; 
Koshiyama et al., 1981; Spink, 2008). The shift in the baseline between pre and post transition area 
is the difference in heat capacity (ΔCp) from the native to denatured protein. In general, the heat 
capacity of a denatured protein is higher than the heat capacity of the folded protein (Edsall, 1935; 
Privalov, 1980; Privalov, 1988; Robertson and Murphy, 1997). 
With (ΔHm), and (ΔCp) it is possible to calculate Gibbs free energy (ΔG(T)) and entropy (ΔS(T)) of 
denaturation at the temperature (T) of interest. Protein stability, in general, is measured by the ΔG 
of denaturation, with a stable protein having a high and positive ΔG. As with spectral studies of 
unfolding, it is important for the unfolding to be fully reversible in order to obtain all these values. 
1.13 Aims and objectives. 
Viral proteins are increasing in importance as they are vital to improvements in the vaccine, 
treatment and diagnostic development. Therefore, an economical and reliable expression protocol 
for full-length Bluetongue virus VP7 is desirable.  
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The aim of this project is to optimize overexpression of full-length Bluetongue virus VP7 using a 
bacterial expression system and to optimize the purification of said Bluetongue virus VP7 so that 
studies into its structure and stability can be undertaken using spectroscopy techniques.  
The objectives of this study are threefold. The first is to test protein expression conditions including 
growth medium, post-induction temperature, inducer concentration and post-induction time of a 
bacterial expression system, consisting of a GenScript® constructed pET28a plasmid containing 
cDNA of polyhistidine-tagged Bluetongue virus VP7 gene sequence transformed into BL21(DE3), 
NiCo21(DE3), C43(DE3) pLysS and KRX Escherichia coli bacterial cells.  
Secondly, is to purify Bluetongue virusVP7 protein using affinity tag chromatography. And lastly, 
when purified Bluetongue virus VP7 is obtained, the characterization of the secondary and tertiary 
structure using far-UV CD, fluorescence and clear native-PAGE. Conformational stability of 
Bluetongue virus VP7 will be determined by increasing temperature or denaturant concentration 
and monitoring protein behaviour using spectroscopic probes (fluorescence and far-UV CD) and 
differential scanning calorimetry. 
2. Materials and Methods. 
2.1 Materials. 
A pET28a plasmid was procured from GenScript® and was generated by inserting the codon 
optimized cDNA, which encodes the Bluetongue virus VP7 consensus sequence (Russell et al., 
2018), segment between the Ndel and Xhol restriction sites and the recombinant plasmid supplied 
to Prof. Samantha Gildenhuys. Confirmation of gene insert in the plasmid was performed by 
GenScript® via sequencing alignment and restriction digests. Kanamycin and isopropyl-β-D-
thiogalactoside were obtained from Melford (Ipswich, United Kingdom). DNase I was obtained from 
Roche Diagnostics (Mannheim, Germany). SDS-PAGE protein molecular mass marker was obtained 
from Thermo Scientific (Massachusetts, United States). DEAE-Sepharose and histidine affinity 
nickel cross-linked agarose resins were obtained from GE Healthcare Life Sciences (Uppsala, 
Sweden) and Macherey-Nagel (Duren, Germany). Ultra-pure urea and Bradford reagent was 
obtained from Sigma-Aldrich (St. Louis, MO USA), and any additional chemicals were of analytical 
grade. 
2.2 Transformation of competent cells and production of glycerol stocks. 
Competent Escherichia coli BL21(DE3), NiCo21(DE3), C43(DE3) pLysS and KRX cells were 
transformed with the pET28a plasmid containing DNA encoding Bluetongue virus viral protein 7 
(VP7).  
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Competent Escherichia coli BL21(DE3), NiCo21(DE3), C43(DE3) pLysS and KRX cells were thawed on 
ice for 15 minutes. Then 3 μl of pET28a plasmid DNA (100 ng.μl-1) was added to 100 μl of competent 
cell mixture and placed on ice for 30 minutes. The BL21(DE3), NiCo21(DE3), C43(DE3) pLysS and 
KRX cells were then heated at 42 °C for 45 seconds, using a heating block, and then rapidly 
transferred to ice for two minutes.  
Then 500 μl of SOC outgrowth media was mixed into the cell mixture followed by an incubation of 
90 minutes at 37 °C with 230 rpm shaking. All cells were plated, using the spread plate technique, 
on LB-agar plates supplemented with 30 μg/ml kanamycin and for the C43(DE3) pLysS cells, an 
additional 30 μg/ml chloramphenicol was used. Agar plates were then incubated at 37 °C for 12-16 
hours. Single colonies were taken from each cell line and added into 20 ml of sterile, fresh LB and 
grown for 12-16 hours, after which a 1:50 dilution was added to fresh LB and grown to mid-log. 
Glycerol stocks were then created by adding equal volumes of 30 % autoclaved glycerol and cell 
culture. The glycerol-cell mixture was frozen at -80 °C until needed. 
2.3 Induction study. 
BL21(DE3), NiCo21(DE3) and C43(DE3) pLysS contain the λDE3 lysogen, which contains the gene for 
T7 RNA polymerase controlled by a lac UVS promoter, which is inducible by IPTG (Studier and 
Moffatt, 1986). In addition, the pET28a plasmid is inducible by IPTG as it contains a lac UV5 
promoter upstream from the target gene, as well as the repressor lacI gene and has kanamycin 
antibiotic resistance, which acts as a selectable marker. The system controlling gene expression in 
this plasmid involves the T7 promoter, from the bacteriophage T7 which is not acknowledged by 
bacterial mRNA polymerase. Instead, the activity of the T7 promoter is regulated by the lac UV5 
promoter, which is situated upstream from the gene of interest (Sorenson and Mortensen, 2005).  
The plasmid contains the LacI gene which encodes the LacI repressor, which allows for its 
production. The LacI repressor blocks the expression of T7 RNA polymerase by binding to the lac 
operator. IPTG binds to the LacI repressor, resulting in structural changes that cause the lac 
operator to be released. This frees the lac UV5 promoter and therefore allows transcription of T7 
RNA polymerase to occur (Sorenson and Mortensen, 2005). The expressed T7 RNA polymerase 
interacts with the T7 promoter, that is situated upstream of the target gene within the plasmid, in 
this case, the gene coding for Bluetongue virus VP7, which is then translated into the Bluetongue 
virus VP7 protein and overexpression occurs. KRX cells contain a copy of T7 RNA polymerase 
modulated by a rhamnose promoter (rhaPBAD), not the UV5 promoter. Rhamnose is able to induce 
the expression of the T7 RNA polymerase, which is then able to transcribe the target gene, in our 
case the Bluetongue virus VP7 gene.  
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Glycerol stocks (50 μl) of all Escherichia coli cell lines containing the pET28a plasmid (with the 
consensus Bluetongue virus VP7 encoding sequence insert) were added to 20 ml sterile, fresh LB 
media inoculated with 30 μg/ml kanamycin for all cell lines and an additional 30 μg/ml 
chloramphenicol for C43(DE3) pLysS cells.  
All cell lines were grown for 12-16 hours at 37 ˚C with 230 rpm shaking, before being inoculated 
into fresh LB media to a dilution of 1:50, containing kanamycin (30 μg/ml) for all cell lines and an 
additional 30 μg/ml chloramphenicol for C43(DE3) pLysS cells. Cells were grown to an OD600 of 
between 0.5 and 0.8  at 37 ˚ C with 230 rpm shaking, before being induced with IPTG concentrations 
of 0.1 mM and 1.0 mM IPTG for BL21(DE3), NiCo21(DE3) and C43(DE3) pLysS cells and 0.1 mM IPTG 
with 0.05 %, 0.1 % and 0.15 % rhamnose for KRX cells. All cells were grown at different post-
induction temperatures between 16 ˚C and 37 ˚C, as well as at various post induction times from 
two to 16 hours.  
BL21(DE3) cells and NiCo21(DE3) cells were grown in two growth mediums, namely Luria-Bertani 
medium (1.0 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 0.5 % (w/v) sodium chloride) and 2xYT 
medium (1.6 % (w/v) tryptone, 1.0 % (w/v) yeast extract, 0.5 % (w/v) sodium chloride). Induction 
was performed when the cell culture produced a reading between 0.5 and 0.8 computed using 
optical density readings with an Implen P330 NanoPhotometer (München, Germany), at 
wavelength of 600 nm. 
After induction, whole cell samples were collected by centrifugation of 1 ml of cell culture for five 
minutes at 12,100 x g. The whole cell pellet obtained from this centrifugation was then 
resuspended in 400 μl. Primary buffer. To analyse the extent of soluble protein expression, the 
soluble (supernatant) and insoluble (pellet) fractions were separated by taking 5 ml of cell culture 
and centrifuging it at 3000 x g for 15 minutes at 4 ˚C and then resuspending it in 700 μl of Lysis 
buffer and this mixture was rotated at 22 ˚C for 20 minutes. The cell mixture was then sonicated 
with a Qsonica Q700 sonicator (Newtown, USA) at 35 amperes for five, 10 second rounds (pulsed 
at two seconds on, one second off) and placed on ice for two minutes in between each cycle for 
BL21(DE3), NiCo21(DE3) and KRX cells and at 60 amperes for five, 10 second (pulsed at two seconds 
on, one second off) for C43(DE3) pLysS. The sonicated cell mixture was then centrifuged for 20 
minutes at 12,100 x g at 4 ˚C before removing the supernatant. The pellet was then re-suspended 
in 700 μl Primary buffer. Sonication and centrifugation were repeated for samples taken at various 
time intervals between two and 16 hours post induction, depending on the cell line. Whole cells, 
supernatant (soluble fraction) and pellet (insoluble fraction) samples were investigated using SDS-
PAGE (see section 2.7.1). 
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2.4 Isolation of inclusion bodies. 
BL21(DE3) and NiCo21(DE3) whole cell samples were defrosted and prepared for separation of 
soluble (supernatant) and insoluble (pellet) fractions as described in section 2.3, with volumes 
altered proportionately.  
As presented in Russell and Gildenhuys (2018), the pellet containing, Bluetongue virus VP7, was 
collected after sonication and centrifugation of whole cell samples and then placed in 50 ml of 
Wash buffer A. The detergent Triton X-100 was used as it facilitates the removal of bacterial cell 
membrane proteins and other cellular debris (Lilie et al., 1998; De Bernardez, 1998; Georgiou and 
Valax, 1999). EDTA was added to prevent the air oxidation of cysteines (Kaur et al., 2017). To isolate 
the bacterial cell inclusion bodies the pellet was washed twice in Wash buffer A and centrifuged at 
12,100 x g for 16 minutes.  
This was followed by resuspending the pellet twice in 50 ml of Wash buffer B and centrifuging at 
12,100 x g for 10 minutes to remove the Triton X-100 as it can interfere with further solubilisation 
and purification. The resulting pellet was used for further solubilisation and purification.  
2.5 Solubilisation of inclusion bodies containing Bluetongue virus VP7. 
To solubilise the inclusion bodies containing Bluetongue virus VP7, a method of freezing the 
inclusion bodies in the presence of urea was used as presented in Russell and Gildenhuys (2018). 
All urea used was prepared as described by Pace (1986) using the necessary buffer for the solvent. 
Urea stock solutions were filtered with a 0.4 μm filter after having the pH adjusted as needed. Stock 
solution concentration of 10 M was confirmed using an Atago R5000 refractometer (Tokyo, Japan). 
The stock solution produced was frozen at -20 ˚C and defrosted on the day needed, stock solutions 
were used within five days of being made.  
Seven urea concentrations were evaluated, namely 2 M, 3 M, 4 M, 5 M, 6 M, 7 M and 8 M urea in 
the Freezing buffer. The urea suspended inclusion bodies were frozen at -20 ˚C for 16 hours and 
defrosted at 22 ˚C before being centrifuged at 12,100 x g for 15 minutes. The degree of protein 
solubilisation was analysed by SDS-PAGE (section 2.7.1). For solubilisation of protein samples for 
ion-exchange chromatography the inclusion bodies were frozen with the same Freezing buffer, but 
with only 20 mM sodium chloride, as the higher concentration of sodium chloride would interfere 
with protein binding to the column. 
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2.6 Purification of solubilized Bluetongue virus VP7. 
2.6.1 Anion-exchange chromatography. 
In anion-exchange chromatography, the binding ions on the proteins have a negative charge and 
the immobilized functional groups in the resin have a positive charge (Adams and Holmes, 1935). 
The isoelectric point for Bluetongue virus VP7 is predicted to be pH 7.07 by ProtParam tool on the 
ExPASy proteomics server (Gasteiger et al., 2005).  
Purification by anion-exchange chromatography of solubilized Bluetongue virus VP7 from 
BL21(DE3) cells was performed using a DEAE-Sepharose (GE Healthcare Life Science, Uppsala, 
Sweden) with one of two buffers. Firstly the column was pre-equilibrated with five column volumes 
of Equilibration buffer A. The sample of solubilized protein from 250 ml of cell culture was diluted 
with Equilibration buffer A and a pH of 9 was confirmed before being applied to the column. Next, 
eight column volumes of Equilibration buffer A were used to wash the column, to wash away any 
unbound protein.  
Bound protein was eluted off the column using five isocratic column volumes of Elution buffer A, 
followed by a linear salt gradient (seven column volumes) from 20 mM to 1 M sodium chloride. The 
gradient was produced by mixing the Elution buffer A with 1 M sodium chloride. 
Secondly, Equilibration buffer B was used to equilibrate the DEAE-Sepharose column. The sample 
of solubilized protein from one litre of cell culture was diluted with Equilibration buffer B and a pH 
of 9 was confirmed before it was applied to the column.  
Five column volumes of Equilibration buffer B were washed through the column, to wash away 
unbound protein. Bound protein was eluted off the column using five column volumes of Elution 
buffer B, followed by a linear salt gradient (seven column volumes) from 20 mM to 1 M sodium 
chloride. The gradient was produced by mixing Elution buffer B with 1 M sodium chloride. 
All urea used was prepared as described in section 2.5. Anion-exchange chromatography was 
coordinated using an ÄKTAprime system with PrimeView 5.31 software (GE Healthcare Life 
Sciences, Uppsala, Sweden). Bluetongue virus VP7 was detected using SDS-PAGE (section 2.7.1) 
analysis of fractions with high 280 nm readings. 
2.6.2 Nickel-IMAC chromatography. 
Solubilized protein from BL21(DE3) and NiCo21(DE3) Escherichia coli inclusion bodies were loaded 
onto two different nickel cross-linked agarose resins, namely Macherey-Nagel Protino® Ni-NTA 
agarose (Duren, Germany) and GE Healthcare Histrap high performance (Uppsala, Sweden).  
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All urea used was prepared as described in section 2.5. Macherey-Nagel Protino® Ni-NTA columns 
were equilibrated with 10 column volumes of Equilibration buffer C. The addition of salt (up to 500 
mM sodium chloride) was added to reduce nonspecific hydrophobic protein interactions with the 
nickel affinity resin (Bornhorst and Falke, 2000). The protein sample consisting of the solubilised 
protein was loaded onto the column. The column was then washed with 10 column volumes of the 
Equilibration buffer C.  
The protein was eluted using a linear gradient (six column volumes) from 0 to 250 mM imidazole 
followed by five isocratic column volumes of Elution buffer C. The gradient was produced by mixing 
the Equilibration buffer C with Elution buffer C. All buffers were filtered using a 0.2 µm filter before 
use. 
GE Healthcare Histrap high performance columns were equilibrated with 10 column volumes of 
Equilibration buffer D. The solubilized protein sample was loaded onto the column. The column 
was then washed with 10 column volumes of the Equilibration buffer D.  
The protein was eluted off by using a linear gradient (six column volumes) from either no initial 
imidazole or 50 mM initial imidazole to 500 mM imidazole, followed by five isocratic column 
volumes of Elution buffer D. The gradient was produced by mixing the Equilibration buffer D with 
Elution buffer D. All buffers were filtered using a 0.2 µm filter before use. 
Nickel-affinity chromatography was conducted using a BioRad NGC™ Chromatography system with 
a computer loaded with ChromLab software (Hercules, USA). Bluetongue virus VP7 was detected 
using SDS-PAGE (section 2.7.1) analysis of fractions with high 280 nm absorbance readings. 
Fractions that were found to contain Bluetongue virus VP7 were then combined and concentrated 
using a Merck Millipore Amicon® Stirred cell and Ultracel® membrane (Darmstadt, Germany). 
Dialysis of concentrated protein samples was performed using three buffer changes, four, six and 
16 hours apart, respectfully. Dialysis was performed at approximately 16 ˚C with a buffer volume 
10 times the sample size volume. Dialysis of concentrated Bluetongue virus VP7 was performed 
into the Primary buffer with the addition of 20 mM sodium chloride, 20 % glycerol and 5 M ultra-
pure urea. A pH value of 6 was used as Bluetongue virus VP7 isoelectric point is predicted as pH 
7.07. Using a buffer with a pH value of at least one point above or below the protein’s pI can help 
in the reduction of protein aggregation as the proteins then contain net charges that help to repel 
individual proteins from one another (Gitlin, 2006).  
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2.7 Gel electrophoresis of proteins. 
2.7.1 SDS-PAGE. 
SDS-PAGE was used to visualise solubility and purity of Bluetongue virus VP7. SDS-PAGE uses 
electrophoresis to separate proteins (Laemmli, 1970) based on their molecular mass. A 15 % 
separating gel and 4 % stacking gel was used in a BioRad Mini-PROTEIN Electrophoresis Cell 
(Hercules, USA). The protein samples were diluted two-fold with SDS-PAGE sample buffer. Protein 
in the SDS-PAGE sample buffer was boiled for 5 minutes. The gel was run in an SDS-PAGE running 
buffer at 160 volts for approximately 1 hour.  
The molecular mass marker used contained a mixture of seven proteins: β-galactosidase (116 kDa), 
bovine serum albumin (66.2 kDa), ovalbumin (45 kDa), lactate dehydrogenase (35 kDa), restriction 
endonuclease Bsp98I (25 kDa), β-lactoglobulin (18.4 kDa) and lysozyme (14.4 kDa).  Each gel was 
then stained with 0.05 % R250 Coomassie Brilliant blue, 10 % acetic acid and 50 % methanol for an 
hour, and then de-stained with 5 % ethanol and 7 % acetic acid solution overnight. A BioRad, 
Universal Hood III (Hercules, USA) gel imaging system was used. 
2.7.2 Clear native PAGE. 
Clear native PAGE samples are prepared in a non-reducing, non-denaturing sample buffer and the 
proteins separated based on molecular mass, structure and charge. Pre-cast BioRad Mini Protein 
TGX Protein Gels with premixed BioRad native PAGE sample and BioRad native PAGE running buffer 
was used. A BioRad Mini-Protein Electrophoresis Cell was used (Hercules, USA). Bluetongue virus 
VP7 was analysed in a number of different buffers.  
Samples were left in BioRad native PAGE sample buffer, and their respective additives, for one hour 
before loading. Samples of Bluetongue virus VP7 in 2 % SDS, 5 M urea and 5 M with 2 % SDS were 
boiled at approximately 100 ˚C, for 8 minutes before being loaded. Samples were boiled to assess 
the ability of high temperatures to denature Bluetongue virus VP7. The gels were run in BioRad 
native-PAGE running buffer at 120 volts for approximately two hours. Each gel was then stained 
with 0.05 % R250 Coomassie Brilliant blue, 10 % acetic acid and 50 % methanol for an hour, and 
then de-stained with 5 % ethanol and 7 % acetic acid solution overnight. A BioRad, Universal Hood 
III (Hercules, USA) gel imaging system was used.  
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2.8 Spectroscopic studies. 
2.8.1 Spectroscopy for protein concentration determination. 
2.8.1.1 Absorbance spectrometry 
Protein concentration can be calculated from absorbance spectroscopy using the Beer-Lambert 
law: 
A = ελcl                              (1) 
where A is the absorbance at the respective wavelength, ελ is the molar extinction coefficient of 
the absorber at wavelength λ (L. mol-1. cm-1), c is the concentration of the absorber (mol. L-1) and l 
is the path length of the cuvette (cm). To calculate the molar extinction coefficient ε of a protein 
the number of tryptophan, tyrosine and cysteine disulfide bonds are obtained and used in the 
following equation described by Perkins (1986): 
Ɛ280 M-1. cm-1=[5550 x ( ƩTrp residues)]+[1340 x ( ƩTyr residues)]+[150 x ( Cys residues )]        (2) 
The molar extinction coefficient for Bluetongue virus VP7 was determined to be 40910 M-1.cm-1 
using formula 2 with Bluetongue virus VP7 containing 5 Trp, 9 Tyr and 3 Cys residues. 
Protein concentration was determined prior to other spectroscopic techniques using an Applied 
Photophysics Chirascan Plus (Leatherhead, United Kingdom) with Photophysics Pro-Data software. 
A quartz cuvette with a path length of 10 mm was used. A bandwidth of 1 mm was used and a 
measurement was recorded for every 1 nm between 360 nm and 220 nm. For every sample, three 
spectra repeats were recorded and averaged. All spectra had buffer contributions subtracted. 
2.8.1.2 Bradford assay 
For confirmation of protein concentration of purified protein samples, a Bradford assay (Bradford, 
1976) was performed using bovine serum albumin as a standard. Colour change was monitored at 
595 nm for a number of bovine serum albumin standards of known concentrations using an Implen 
P330 NanoPhotometer (München, Germany). The concentration of the purified Bluetongue virus 
VP7 was determined by comparison to the standards of which the concentration is known. 
2.8.2 Far-UV circular dichroism. 
Far-UV Circular Dichroism spectra were recorded using an Applied Photophysics Chirascan Plus 
(Leatherhead, United Kingdom) with Photophysics Pro-Data software. Wavelengths between 250 
nm to 190 nm were evaluated at 22 ˚C using a 1 mm quartz cuvette with a step size between 
measurements of 1 nm, bandwidth of 1 nm and scan speed of 2 nm per second. A quartz cuvette 
was used as quartz does not absorb light in the wavelength range being studied (Kelly and Price, 
2000).  
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Spectra values collected were converted to mean residue ellipticity with the formula: 
[θ] = 100 (signal)/ Cnl      (3) 
where C is the concentration of protein in mM, n is the number of amino acid residues and l is the 
path length in cm. For every sample, three spectra repeats were recorded and averaged. All spectra 
had buffer contributions subtracted. 
2.8.3 Intrinsic fluorescence.  
Fluorescence spectra were collected at 22 ˚C, using an Applied Photophysics Chirascan Plus 
(Leatherhead, United Kingdom) with Photophysics Pro-Data software and a 10 mm quartz cuvette, 
a bandwidth of 1 mm, step size of 1 nm and wavelength range 500 nm and 275 nm, with excitation 
wavelength set at 295 nm. For every sample, three spectra repeats were recorded and averaged. 
All spectra had buffer contributions subtracted. 
Bluetongue virus VP7, as mentioned in the introduction, contains 5 tryptophan residues, namely 
Trp119, Trp141, Trp188, Trp255 and Trp 278. The positioning of tryptophan residues can be seen 
in Figure 2.1, showing that residue Trp278 is completely buried in the folded protein and therefore 
not represented on the diagram, and Trp225 is predominantly buried. Trp119, Trp141 and Trp188 
are all predominantly exposed in the folded protein. 
2.8.4 Protein unfolding. 
Heat and denaturants such as urea and guanidinium chloride are capable of unfolding native 
proteins (Schmid, 2001). Therefore a protein’s stability can be tested by subjecting it to the 
different conditions and measuring the fluorescence spectra. More specifically the intensity and 
wavelength emission maxima of tryptophan for each desired condition as well as the far-UV circular 
dichroism spectrum for the presence or absence of characteristic secondary structure 
measurements (Kelly and Price, 2000). Far-UV CD and fluorescence were used to monitor the 
stability of the protein by displaying how the secondary and tertiary structure changes in response 
to changes in buffer conditions.  
Far-UV circular dichroism and fluorescence spectra were obtained as described in section 2.8.2 and 
2.8.3 while increasing the temperature of the protein sample from 20 ˚C to 90 ˚C. The temperature 
was maintained by a PCS.3 Single Cell Peltier Temperature Controller, with a circulating chiller unit 
that is programmed by the Chirascan’s Pro-Data software (Leatherhead, United Kingdom). 
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Figure 2.1. Tryptophan residues in Bluetongue virus VP7. 
Diagram showing Bluetongue virus VP7 monomer depicting positioning of tryptophan residues, 
showing surface exposure. Tryptophan residues are highlighted in pink and are numbered with their 
corresponding residue number. Trp278 is completely buried in the folded protein and is therefore 
not represented on the diagram. Two orientations of the protein are shown with the two domains 
found in a Bluetongue virus VP7 molecule labelled beta-sandwich and alpha-helical on the diagram 
to help orientate the protein. The structure was obtained from the protein data bank (1BVP) and 
viewed with PyMOL Molecular Graphics System (1.3rl Edu), Schrödinger, LLC. 
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A spectrum was recorded every two degrees between 20 ˚C and 90 ˚C. A final spectrum was 
recorded when the protein sample was cooled to 20 ˚C after being heated to 90 ˚C. For far-UV CD 
the spectrum was recorded between 250 nm and 210 nm, and for fluorescence, the spectrum was 
recorded between 500 nm and 280 nm.  
Bluetongue virus VP7 was tested in the presence of urea and guanidinium chloride. All urea used 
was prepared as described in section 2.5. Guanidinium chloride was prepared as described by Pace 
(1986) using the necessary buffer as the solvent. pH was adjusted as needed before being filtered 
with a 0.4 μm filter. Stock solution concentrations were confirmed using an Atago R5000 
Refractometer (Tokyo, Japan), using refractive indices described by Pace (1986) and Nozaki (1972). 
Stock solutions were used within a week of being made. Samples were prepared in buffers 
containing the desired denaturant concentration, by addition of denaturant stock solutions, for at 
least three hours. For guanidinium chloride refolding studies were undertaken by diluting the 
protein back down from 6 M to 1 M by the addition of Primary buffer at a rate of a decrease of 1 
M each time. Protein samples were allowed to fold for one hour before spectra were recorded. 
Spectra were recorded at 22 ˚C as described in section 2.8.2 and 2.8.3. 
2.9 Differential scanning calorimetry.  
Thermal stability of the protein was evaluated using a TA Instruments Nano Differential scanning 
calorimeter (New Castle, Delaware) with DSCRun software version 4.4.25. Data collected was 
analysed using NanoAnalyze version 3.7.5. Thermal stability is expressed as Tm (peak temperature, 
in ˚C or K) and is an approximation of the temperature at which 50 % of the proteins in the sample 
are denatured.  
A buffer to buffer reaction (Primary buffer with 5 M urea) was recorded first (buffer in sample and 
reference cell) to produce a baseline for subtraction. Next, the protein sample containing 
Bluetongue virus VP7 was loaded into the sample cell with buffer (Primary buffer with 5 M urea) in 
the reference cell. All samples were degassed for approximately 10 minutes before use. 
Thermograms were collected as the protein was heated from 10 ˚C to 100 ˚C with a scan speed of 
1 ˚C/min. Thermal stability is expressed as Tm (peak temperature, in ˚C or K) and is closely related 
to the temperature of denaturation. 
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3. Results. 
3.1 BL21(DE3) Cells. 
BL21(DE3) is a derivative of Escherichia coli BL21 that has a chromosomal DE3 prophage that is able 
to express T7 RNA polymerase. BL21(DE3) was tested first as it is one of the most extensively used 
Escherichia coli strains to check basic protein expression in Escherichia coli (Joseph et al., 2015). 
3.1.1 Expression. 
Protein expression in BL21(DE3) cells was evaluated using four variables, namely (1) post induction 
time (Figure 3.1A), (2) cell growth medium (Figure 3.1B), (3) post induction temperature (Figure 
3.1C) and (4) Inducer concentration (Figure 3.1D).  
Soluble (supernatant) and insoluble (pellet) fractions were visualised using SDS-PAGE (see section 
2.7.1). Each protein’s mass was determined by comparing the protein’s migratory distance to the 
distance travelled by proteins of known molecular mass, under the same conditions. A mass of 41 
kDa was obtained, which is consistent with the size of 38 kDa for Bluetongue virus VP7 (Basak et 
al., 1992; Grimes et al., 1995) with both a C and N terminal polyhistidine tag and a thrombin 
cleavage site. This would place the protein between the sizes of ovalbumin (45 kDa) and lactate 
dehydrogenase (35 kDa) in the protein marker (Figure 3.1E).  
When post induction time was evaluated (Figure 3.1A), a large increase in expression of Bluetongue 
virus VP7 was seen between two and three hours, a gradual increase between three and four hours 
and four and five hours and a large increase between five hours and 16 hours. The large increase 
between two and three hours can be attributed to there being low cell numbers at two hours 
compared to three hours. The larger increase between five and 16 hours could at least in part be 
attributed to larger cell numbers produced over the increased growing time, as even though the 
cells would reach stationary phase within this time frame, cell growth and death are still occurring 
and seeing as the media creates a closed system, the protein becomes more concentrated. This is 
supported by the increase in all expressed bacterial proteins in the sample. Very little Bluetongue 
virus VP7 appears to be expressed in soluble form (seen in the supernatant fraction), and no 
apparent increase in soluble Bluetongue virus VP7 expression occurs over time. 
When cell growth medium was evaluated, two compositions were used, namely Luria-Bertani (LB) 
medium and 2xYT medium (Figure 3.1B). The medium types were assessed as Luria-Bertani medium 
is the most commonly used growth medium for bacterial cells (Bertani et al., 1951) and 2xYT media 
is richer in the metabolites needed by bacterial cells, and therefore is known to increase protein 
and cell yields (Miller, 1972; Lessard, 2013).  
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Figure 3.1. Bluetongue virus VP7 expression in BL21(DE3) cells.  
SDS-PAGE showing expression of Bluetongue virus VP7 (marked with a purple arrow) in BL21(DE3) 
cells when varying four different expression conditions namely (A) post induction time, (B) cell 
growth media, (C) post induction temperature and (D) inducer concentration. Expression conditions 
kept constant are indicated above each gel. “Sup” represents supernatant and “Pe” represents 
pellet samples. (E) A calibration curve showing Bluetongue virus VP7 migrating a distance that 
corresponds to the size of 41 kDa with the position of Bluetongue virus VP7 marked with an (x) and 
size and names of proteins found within protein marker indicated. Selected data used in this Figure 
was published in Russell and Gildenhuys (2018).  
37 
 
SDS-PAGE analysis showed little difference in protein expression in either the soluble (supernatant) 
or insoluble (pellet) fractions, with the predominance of expression being seen again in the 
insoluble fraction (pellet) for both mediums (Figure 3.1B). Therefore, as 2xYT has a greater cost due 
to the increased percentage of tryptone and yeast, the logical choice would be to use LB medium 
as a similar yield is obtained at a lower cost. 
When post induction temperature was assessed, cells were grown after induction at 16 ˚C and 37 
˚C (Figure 3.1C). SDS-PAGE showed an increase in Bluetongue virus VP7 expression at 37 ˚C 
compared to 16 ˚C, however, there is also an increase in other bacterial proteins expressed, and 
therefore at least part of the increase at 37 ˚C could be due to increased cell numbers after five 
hours at the higher temperature. This is supported by Farewell and Neidhardt (1998) and Noor et 
al. (2013) who reported increased Escherichia coli cell growth at higher temperatures compared to 
lower temperatures. Growing cells as 16 ˚C has been known to produce soluble expression of 
proteins that are insolubly expressed at higher temperatures (Hockney, 1994; Makrides, 1996). 
However, growing BL21(DE3) cells containing the Bluetongue virus VP7 insert at 16 ˚C still resulted 
in a larger quantity of expression being in the insoluble fraction (pellet). 
And lastly, two inducer concentrations were tested, namely 0.1 mM and 1.0 mM (Figure 3.1D). 
Little expression difference was seen between the two inducer concentrations, with both resulting 
in Bluetongue virus VP7 expression occurring predominantly in the insoluble fraction (pellet). 
The chosen conditions for protein expression in BL21(DE3) cells were five hour post-induction 
growth, at 37 ˚C with 0.1 mM IPTG in LB medium. This was to help prevent the stress placed on 
bacterial cells that are grown for long periods of time, but still allowing for adequate time for the 
expression of Bluetongue virus VP7 in a higher proportion to other cellular proteins (Bentley and 
Kompala, 1990).  
3.1.2 Solubilisation.  
The lack of soluble expression of Bluetongue virus VP7 in BL21(DE3) cells resulted in the need to 
solubilize the protein found in inclusion bodies in the bacterial cell pellet. Cellular debris, including 
bacterial cell wall, membrane components, proteins, and residual soluble proteins, accumulate in 
the insoluble fraction (pellet) after sonication and centrifugation. These contaminating 
components can be removed with the use of detergents (such as Triton X-100) and a low 
concentration of urea or guanidinium chloride, resulting in ‘washed pellets’ (Palmer and Wingfield, 
2004). As seen in Figure 3.2A SDS-PAGE analysis depicts several wash steps that were undertaken 
to remove the contaminating bacterial components, and therefore isolate the inclusion bodies.  
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Figure 3.2. Solubilisation of BL21(DE3) inclusion bodies.  
SDS-PAGE analysis of results obtained from the protocol for solubilizing BL21(DE3) inclusion bodies. 
(A) Supernatant and pellet fractions of numbered wash steps, Wash A is with Wash buffer A 
(containing Triton X-100) and Wash B is with Wash buffer B (buffer components in List of Buffers on 
page xiv). (B) Shows supernatant and pellet samples after centrifugation of the defrosted inclusion 
bodies in different urea concentrations, depicted as ‘x’M, where ‘x’ is the urea concentration that 
the sample was frozen in. “Sup” is the supernatant, “Pe” is the resuspended pellet. BUF is the 
samples before being frozen in urea. Molecular mass marker (marked as “M”) has sizes in kDa, 
marked on the gel. The position of Bluetongue virus VP7 is marked with purple arrows. Selected 
data used in this Figure was published in Russell and Gildenhuys (2018).  
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Triton X-100 causes disruption in SDS-PAGE and thus is the cause of the smudging and apparent 
lower concentrations seen for samples that contain it (Figure 3.2A). Bluetongue virus VP7 was 
solubilised from bacterial inclusion bodies using urea and a freeze-thaw step modified from the 
protocol presented by Qi et al. (2015). The Wash buffer B step was repeated so that all of the Triton 
X-100 was removed before solubilisation. As seen in Figure 3.2B less than half of the pellet is 
solubilized with urea concentrations of 3 M and below, with a similar high level of solubilisation for 
urea concentrations of 4 M and above. There appears to be a slight increase between 4 M and 5 
M, and then no further increase after that. The urea concentration for solubilisation of at least 95 
% of the proteins within the bacterial inclusion bodies including Bluetongue virus VP7 was 5 M urea 
for BL21(DE3) cells (Figure 3.2B). 
3.1.3 Purification. 
Solubilized proteins from BL21(DE3) cell inclusion bodies were loaded onto a pre-equilibrated 
DEAE-Sepharose column using two different buffers as explained in methods. The two buffers were 
tested as ion-exchange chromatography is sensitive to the ionic strength and type of buffer 
compound used, as an increase in ionic strength decreases protein binding to the column as 
competing ions are increased. Sodium phosphate buffers are said to have a higher ionic strength 
than Tris-HCl buffers at a given concentration (Good and Izawa, 1972). When the solubilized protein 
mixture containing Bluetongue virus VP7 was loaded onto columns equilibrated with both 
Equilibration buffer A (containing sodium phosphate) (Figure 3.3A) and Equilibration buffer B 
(containing Tris-HCl) (Figure 3.3B), Bluetongue virus VP7 bound the column and was eluted off at 
approximately 250-300 mM sodium chloride and not during pH elution step.  
The pH elution step is indicated in Figure 3.3A and B with no visible peaks occurring. With both 
buffers, multiple other bacterial cellular proteins bound and were eluted from the column under 
the same conditions as Bluetongue virus VP7, despite a salt gradient being used. Therefore, further 
purification would be needed. For Equilibration buffer A, solubilized protein from 250 ml of LB 
culture was used and for Equilibration buffer B, 1000 ml of LB culture was used, explaining 
discrepancies in the 280 nm absorbance seen. Changes in elution profiles such as peak positioning 
and values between Figure 3.3 A and B could potentially be due to changes in ionic strength of the 
different buffers used. 
Next, solubilized protein from BL21(DE3) cell inclusion bodies were loaded onto a pre-equilibrated 
nickel affinity column. Two different nickel cross linked agarose resins were tested, namely 
Macherey-Nagel Protino® Ni-NTA agarose and GE Healthcare Histrap high performance Ni 
Sepharose.  
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Figure 3.3. Ion-exchange chromatography purification of solubilised Bluetongue virus VP7 from 
BL21(DE3) cells. 
A DEAE-Sepharose ion-exchange chromatography purification of solubilised protein from inclusion 
bodies produced by BL21 (DE3) cells for (A) Equilibration and  Elution buffer A (B) Equilibration and  
Elution buffer B. Chromatograms are shown where the A280 effluent (blue), sodium chloride gradient 
(green), conductivity (red) and fractions collected (numbered and marked with ‘x’) are depicted. As 
well as SDS-PAGE analysis of certain fractions depicted as “FX” on SDS-PAGE, where ‘X’ represents 
the fraction number. “Pe” is the sample loaded onto the column. Molecular mass marker (marked 
as “M”) has sizes in kDa, marked on the gel. The position of Bluetongue virus VP7 is marked with 
purple arrows. Purification performed using and ÄKTAprime system with PrimeView 5.31 software.  
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Firstly the Macherey-Nagel Protino® Ni-NTA agarose was tested (Figure 3.4A) which resulted in 
solubilized Bluetongue virus VP7 binding the column pre-equilibrated and washed with 
Equilibration buffer C. However, multiple other bacterial proteins bound under the same 
conditions, and were eluted along with Bluetongue virus VP7 from approximately 150 mM 
imidazole (approximately 60 % through gradient). This is seen in the chromatogram (Figure 3.4A) 
which shows an elongated elution peak containing Bluetongue virus VP7 (fractions 4 to 11) with at 
least two peaks within it (fractions 5 and 6). 
Some Bluetongue virus VP7 was also seen to not bind the column, and instead came through in the 
buffer wash before elution, this may be due to the Macherey-Nagel Protino® Ni-NTA column 
reaching binding capacity due to a large amount of non-specific bacterial cell protein binding seen, 
both eluted before and with Bluetongue virus VP7 elution.  
The GE Healthcare Histrap high performance purification of Bluetongue virus VP7 from BL21(DE3) 
cells required two chromatographic steps, as the initial step without imidazole in Equilibration 
buffer D (Figure 3.4B) resulted in other bacterial proteins binding and eluting with Bluetongue virus 
VP7, the same is seen with the Macherey-Nagel Protino® Ni-NTA agarose. However, the 
chromatogram showed more defined peaks at fraction 4 and 6-7 with elution of Bluetongue virus 
VP7 occurring over fraction 4 to 12. 
The decrease in non-specific binding of bacterial proteins seen for the GE Healthcare Histrap high 
performance columns resulted in them being used for further studies. Bluetongue virus VP7 was 
eluted from a concentration of approximately 300 mM imidazole (approximately 60 % through the 
gradient). The fractions collected that contained Bluetongue virus VP7 were loaded onto the same 
column pre-equilibrated with Equilibration buffer D, with 50 mM imidazole, after being diluted 8-
fold with the same Equilibration buffer D to obtain a concentration of approximately 50 mM 
imidazole in the sample as well. When imidazole was added to the Equilibration buffer D (Figure 
3.4C), Bluetongue virus VP7 was found to still bind the column and be eluted off at an imidazole 
concentration between 300-500 mM, with the chromatogram (Figure 3.4C) showing a double peak 
over fractions 2 to 4 and 6 to 9. For Figure 3.4C the smudging of samples in SDS-PAGE is caused by 
the presence of urea and high sodium chloride concentrations in the samples. 
For proteins that have a polyhistidine tag on both the C and N terminals, it has been seen that they 
bind the column resin more tightly, requiring a higher imidazole concentration to elute the protein 
off the column (Khan et al., 2006). This is seen for Bluetongue virus VP7, as an imidazole 
concentration of up to 500 nm is required to elute it off the column.   
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Figure 3.4. Nickel-affinity purification of Bluetongue virus VP7 solubilised from BL21(DE3) cells. 
Nickel-affinity purification for proteins, including Bluetongue virus VP7, solubilised from BL21(DE3) 
cell inclusion bodies using (A) Macherey-Nagel Protino® Ni-NTA agarose column (B) GE Healthcare 
Histrap High performance column (C) GE Healthcare Histrap High performance column with 
imidazole in Equilibration buffer D. Each showing chromatogram where the A280 effluent (blue), 
imidazole gradient (green) and conductivity (red) and fractions collected (numbered and marked 
with ‘x’) were recorded. For SDS-PAGE analysis certain fractions were visualised (depicted as “FX”, 
where X is the fraction number) and fractions that were combined and concentrated are labelled 
“FX-FX conc”. The sample loaded is indicated and FT is the flow through. The molecular mass marker 
(marked as “M”) has sizes in kDa, marked on the gel. The position of Bluetongue virus VP7 is marked 
with purple arrows. Purification performed using and BioRad NGC™ Chromatography system with 
a computer loaded with ChromLab software (Hercules, USA). Selected data used in this Figure was 
published in Russell and Gildenhuys (2018).  
43 
 
It has also been seen that the proteins containing a polyhistidine tag on both the C and N terminal 
caused multiple elution peaks of the same protein due to slightly different binding contributions 
from both tags (Khan et al., 2006). This double peak elution is seen for Bluetongue virus VP7 in 
Figure 3.4 and again later in section 3.2.3 Figure 3.8, and is presumably due to Bluetongue virus 
VP7 containing both a C and N terminal polyhistidine tag. This is advantageous as the requirement 
of the higher imidazole concentration for Bluetongue virus VP7 elution allows for a level of high 
purity from purification. 
The differences seen in non-specific bacterial protein binding between Macherey-Nagel Protino® 
Ni-NTA column and GE Healthcare Histrap high performance column were seen for NiCo21(DE3) 
cells as well (section 3.2.3), despite these cells being genetically modified to decrease non-specific 
binding of bacterial cells during IMAC purification.  
Different structural matrices between the two column types or the different pH conditions required 
by the two columns could be the cause of the differences seen. Both columns are meant to provide 
low metal ion leaching and therefore higher protein purity, however, it has been seen that matrices 
that have a lower specificity often require a lower imidazole concentration to elute the protein of 
interest than matrices with higher specificity (Bornhorst and Falke, 2000; Block et al., 2009). 
Macherey-Nagel Protino® NI-NTA columns explain that they have NTA matrix, however GE 
Healthcare Histrap high performance resin does not give details on their structure, but Bluetongue 
virus VP7 elutes off the Macherey-Nagel Protino® Ni-NTA column at a much lower imidazole 
concentration (150-250 mM) compared to the GE Healthcare Histrap high performance column 
(350-500 mM). 
That being said, another potentially significant difference between the two columns is the buffer 
conditions used, and more specifically the pH at which the purification needs to occur. Macherey-
Nagel Protino® Ni-NTA column needs a higher pH of 8 compared to GE Healthcare Histrap high 
performance column requiring a pH of 7.4. As proteins are sensitive to changes in pH and more 
specifically Rotavirus VP6, the equivalent protein in a related Reoviridae virus (Lepault et al., 2001), 
pH differences could alter protein binding. The lower efficacy of the Macherey-Nagel Protino® Ni-
NTA column, even with the NiCo21(DE3) cells that have been genetically modified to reduce non-
specific binding during IMAC purification, resulted in the GE Healthcare Histrap high performance 
columns being used for further studies. 
For all purifications, Bluetongue virus VP7 bound the column and was eluted within the imidazole 
gradient. Fractions with high A280 absorbance readings were analysed with SDS-PAGE.  
44 
 
Fractions that were found to contain Bluetongue virus VP7 were then combined and concentrated 
(Figure 3.4). Buffers used during purification contained 500 mM sodium chloride as well as 
imidazole for certain purifications to help prevent non-specific binding. This did not prevent binding 
of non-specific bacterial proteins but instead caused them to bind less tightly and thus be eluted 
first at lower imidazole concentrations (Figure 3.4A, SDS-PAGE lane F2 and Figure 3.4B, SDS-PAGE 
lane F1 and F2).  
Affinity chromatography resulted in polyhistidine tagged Bluetongue virus VP7 being eluted with 
approximate 95 % purity as estimated using BioRad Image LabTM software version 6.0.1 (Hercules, 
USA) “Relative Quantity” tool. The absorbance spectrum of purified Bluetongue virus VP7 was 
recorded (Figure 3.5) and A280 value used to obtain protein concentration using equation 1. Due to 
the noise present in the absorbance spectrum produced (Figure 3.5), the protein concentration was 
further confirmed using Bradford assay as described in section 2.8.1.2. The stock concentration was 
determined to be 13 μM, and therefore approximately 5 mg/250ml cell culture of purified 
Bluetongue virus VP7 was obtained from BL21(DE3) cells. 
3.2 NiCo21(DE3) cells. 
Non-specific binding of bacterial cellular proteins occurred for BL21(DE3) cells, both before 
Bluetongue virus VP7 was eluted and with Bluetongue virus VP7 when no imidazole was added to 
the Equilibration buffer C and D. It is therefore evident that numerous bacterial cellular proteins 
bind the nickel histidine affinity resin. NiCo21(DE3) Escherichia coli cells were tested as they are 
derived from modified BL21(DE3) cells to help reduce Escherichia coli protein binding during IMAC 
purification for polyhistidine-tagged proteins. The proteins GlmS, SlyD,  Can and ArnA have been 
modified to either not bind or be easily eluted off during purification, aiding in an improved purity 
of target proteins isolated using IMAC (Robichon et al., 2011). 
3.2.1 Expression. 
As with BL21(DE3) cells, protein expression in NiCo21(DE3) cells were evaluated using four 
variables, namely (1) post induction time (Figure 3.6A), (2) cell growth media (Figure 3.6B), (3) post 
induction temperature (Figure 3.6C) and (4) inducer concentration (Figure 3.6D). 
Similar to section 3.1.1 through SDS-PAGE analysis and construction of calibration curves, a size of 
41 kDa was obtained for the overexpressed protein, consistent with a size of 38 kDa for Bluetongue 
virus VP7 protein (Basak et al., 1992; Grimes et al., 1995) with both a C and N terminal polyhistidine 
tag and a thrombin cleavage site. This would place the protein in between ovalbumin (45 kDa) and 
lactate dehydrogenase (35 kDa) in the protein marker.  
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Figure 3.5. Absorbance spectrum of purified Bluetongue virus VP7 from BL21(DE3) cells. 
Stock Bluetongue virus VP7 was scanned from 240-340 nm, yielding the above absorbance 
spectrum. The spectrum was recorded in Primary buffer with 5 M urea using an Applied 
Photophysics Chirascan Plus (Leatherhead, United Kingdom) at 20 °C. 
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Figure 3.6. Expression of Bluetongue virus VP7 in NiCo21(DE3) cells.  
SDS-PAGE analysis of Bluetongue virus VP7 expression when varying four different expression 
conditions namely (A) post induction time, (B) cell growth media, (C) post induction temperature 
and (D) inducer concentration. Expression conditions kept constant are indicated above each gel. 
“WC” is whole cell, “Sup” is supernatant and “Pe” is pellet samples that were obtained and 
visualised. Bluetongue virus VP7 migrated a distance that corresponds to the size of 41 kDa with 
the position of Bluetongue virus VP7 marked on the gels with purple arrows. Selected data used in 
this Figure was published in Russell and Gildenhuys (2018).  
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Expression of Bluetongue virus VP7 at different post induction times (Figure 3.6A) revealed a steady 
increase in expression in whole cell samples over the time period of two to 16 hours post induction. 
However, as the expression of all bacterial proteins found in the sample also increased over time, 
at least part of the increase in Bluetongue virus VP7 expression can be attributed to an increase in 
cell number over an increasing growth period. This increase was again seen in the supernatant and 
pellet samples taken, however, these revealed that the expression of Bluetongue virus VP7 
occurred predominantly in the insoluble (pellet) fraction, with very little increase in soluble 
expression of Bluetongue virus VP7 over time. As with BL21(DE3) cells (section 3.1.1) there is a large 
increase between two and three hours, with a small increase between three and four hours, 
however in NICo21(DE3) cells there is a larger increase between four and five hours and the largest 
increase in protein expression is seen between five and 16 hours. The large increase between five 
and 16 hours is predominantly due to the increase in cell density due to the longer growth time as 
explained in section 3.1.1, again supported by the large increase in expression of bacterial cellular 
proteins. 
When NiCo21(DE3) cells were grown in two cell growth mediums, namely Luria-Bertani (LB) 
medium and 2xYT medium, (Figure 3.6B), there was a marked increase in protein expression in the 
cells grown in 2xYT compared to LB, however there is a marked increase in all bacterial protein 
expression, so again this could be due to an increase in cell numbers, in other words, cell yield, due 
to the increase in nutrients in the media as 2xYT medium has been known to increase bacterial cell 
yield (Miller, 1972; Lessard, 2013). 
Post induction temperature (Figure 3.6C) resulted in increased Bluetongue virus VP7 expression 
occurring when cells were grown at 37 ˚C post induction compared to 16 ˚C post induction, with 
predominant expression occurring in the insoluble fraction (pellet). Lowering post induction 
temperature, therefore, did not increase soluble (supernatant) expression in NiCo21(DE3) cells. 
Two inducer concentrations were tested (Figure 3.6D), namely 0.1 mM and 1.0 mM IPTG with little 
difference between the expression of Bluetongue virus VP7 at the lower and higher IPTG 
concentration. At both inducer concentrations, the expression of Bluetongue virus VP7 occurred 
predominantly in the insoluble fraction (pellet). 
As with BL21(DE3) cells, five hour post-induction growth, at 37 ˚C with 0.1 mM IPTG in LB medium 
were the chosen conditions for protein expression in NiCo21(DE3) cells. This was to help prevent 
the stress placed on bacterial cells that are grown for long periods of time, but still allowing for 
adequate time for the expression of Bluetongue virus VP7 in a higher proportion to other cellular 
proteins (Bentley and Kompala, 1990). 
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Although expression in 2xYT created a much larger yield than LB media, studies have reported that 
inclusion body formation under more stressed conditions such as higher temperatures, higher 
inducer concentration and longer times can result in poorer quality protein within the inclusion 
bodies (Bentley et al., 1990; Sanchez de Groot and Ventura, 2006; Jürgen et al., 2010). The 
increased cell yield could potentially cause cell stress and result in a different quality of protein 
from BL21(DE3) cells grown in LB, therefore LB was chosen for further studies for a more direct 
comparison between the cell lines. 
3.2.2 Solubilisation. 
As with BL21(DE3) cells, the lack of soluble expression of Bluetongue virus VP7 resulted in the need 
to solubilize the protein found in the bacterial cell pellet. As seen in Figure 3.7A SDS-PAGE was used 
to depict several wash steps that were undertaken as mentioned in section 3.1.2, the ‘washing’ 
process used the detergent Triton X-100 and urea to remove cellular debris, including bacterial cell 
walls, bacterial membrane components, proteins and residual soluble proteins that accumulate in 
the insoluble fraction (pellet) after sonication and centrifugation (Palmer and Wingfield, 2004) and 
thus isolates the inclusion bodies.  
Triton X-100 causes disruption in SDS-PAGE and thus is the cause of the smudging and apparent 
lower concentrations seen for samples that contain it (Figure 3.7B). Bluetongue virus VP7 was 
solubilised from bacterial inclusion bodies using urea and a freeze-thaw step modified from the 
protocol presented by Qi et al. (2015). The Wash buffer B’s wash step was repeated so that all of 
the Triton X-100 was removed before solubilisation. As seen in Figure 3.7B, less than half of the 
pellet is solubilized with urea concentrations of 3 M and below, with a large increase between 3 M 
and 4 M. There is a slight increase seen between 4 M and 5 M urea, and then a decrease in the 
amount of Bluetongue virus VP7 found in the solubilized supernatant for 6 M, 7 M and 8 M. This 
could be due to the inclusion body pellet precipitating in the higher urea concentrations and 
therefore not allowing solubilisation to occur. The urea concentration for solubilisation of at least 
95 % of the inclusion body proteins, including Bluetongue virus VP7, was 5 M Urea for NiCo21(DE3) 
cells, and this was used for all further work (Figure 3.7B).  
3.2.3 Purification. 
Protein solubilized from the NiCo21(DE3) cell inclusion bodies were loaded onto a pre-
equilibrated metal affinity column. As with BL21(DE3) cells, two different nickel cross-linked 
agarose resins were tested, namely Macherey-Nagel Protino® Ni-NTA agarose and GE Healthcare 
Histrap high performance. 
49 
 
 
 
 
Figure 3.7. Solubilisation of NiCo21(DE3) inclusion bodies. 
SDS-PAGE analysis of results obtained from the protocol for solubilizing NiCo21(DE3) inclusion 
bodies. (A) Supernatant and pellet fractions of numbered wash steps, Wash A is with Wash buffer 
A (containing Triton X-100) and Wash B is with Wash buffer B (buffer components in List of Buffers 
on page xiv).  (B) Shows supernatant and pellet samples after centrifugation of the defrosted 
inclusion bodies in different urea concentrations, depicted as ‘x’M, where ‘x’ is the urea 
concentration that the sample was frozen in. “Sup” is the supernatant, “Pe” is the resuspended 
pellet. BUF is the samples before being frozen in urea. Molecular mass marker (marked as “M”) has 
sizes in kDa, marked on the gel. The position of Bluetongue virus VP7 is marked with purple arrows. 
Selected data used in this Figure was published in Russell and Gildenhuys (2018).  
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Firstly, the Macherey-Nagel Protino® Ni-NTA column was tested (Figure 3.8A) which resulted in 
solubilized Bluetongue virus VP7 binding the column under the chosen conditions, however, other 
bacterial proteins bound under the same conditions, and were eluted along with Bluetongue virus 
VP7 from approximately 150 mM imidazole (Figure 3.8A, SDS-PAGE lane F5), but was 
predominantly eluted at 250 mM imidazole (Figure 3.8A, SDS-PAGE lane F8). The chromatogram 
(Figure 3.8A) shows a broad elution peak containing Bluetongue virus VP7 (fractions 5 to 13), with 
at least three separate peaks within it (fraction 5, 8 and 9). Some Bluetongue virus VP7 was also 
seen to not bind the column, and instead came through in the buffer wash before elution (Figure 
3.8A, SDS-PAGE lane FT1), this could potentially be due to Macherey-Nagel Protino® Ni-NTA 
reaching its capacity, due to the large quantity of non-specific bacterial protein binding seen. 
In comparison to the purification of solubilized proteins from BL21(DE3) cells on the Macherey-
Nagel Protino® Ni-NTA agarose, there appears to be less bacterial cell proteins bound and eluted 
with Bluetongue virus VP7, seen with the chromatogram and SDS-PAGE analysis of fractions (Figure 
3.4A and 3.8A). More significantly there is a large decrease in the number of bacterial proteins that 
bound and were eluted with a lower imidazole concentration of approximately 100 mM. 
In fact, approximately a third of the amount of protein bound and was eluted at 100 mM imidazole 
from NiCo21(DE3) cells, compared to BL21(DE3) cells, as seen through absorbance readings in 
Figure 3.4A and 3.8A as well as corresponding SDS-PAGE analysis of the appropriate fractions. This 
is consistent with NiCo21(DE3) cells being genetically modified to decrease non-specific binding of 
bacterial proteins during purification. 
Secondly, the GE Healthcare Histrap high performance resin Bluetongue virus VP7 binding and 
elution was tested without imidazole in the Equilibration buffer D and sample (Figure 3.8B). 
Bluetongue virus VP7 bound the column and was eluted from an imidazole concentration of 
approximately 300-500 mM. This result is comparable to the solubilised protein from BL21(DE3) 
cells that were purified using the GE Healthcare Histrap high performance with 50 mM imidazole 
in the Equilibration buffer D and sample. This is consistent with the fact that NiCo21(DE3) cells have 
been genetically modified to contain less bacterial proteins that are capable of binding to an IMAC 
column.  
That being said, the chromatogram in Figure 3.8B shows a higher degree of similarity to Figure 3.4B 
of BL21(DE3) cells on the GE Healthcare Histrap high performance column without imidazole in the 
Equilibration buffer D. However, the absorbance reading of the first peak which occurs at an 
imidazole concentration of approximately 180 mM is less for BL21(DE3) cells compared to 
NiCo21(DE3) cells.  
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Figure 3.8. Nickel-affinity purification of Bluetongue virus VP7 from NiCo21(DE3) cells.  
Nickel-affinity purification of protein solubilised from NiCo21(DE3) cell inclusion bodies using (A) 
Macherey-Nagel Protino® Ni-NTA agarose column and (B) GE healthcare Histrap high performance 
column. Each showing chromatogram where the A280 effluent (blue), imidazole gradient (green) and 
conductivity (red) and fractions collected (numbered and marked with an ‘x’) were recorded. For 
SDS-PAGE analysis certain fractions were visualised (depicted as “FX”, where X is the fraction 
number). Fractions that contained Bluetongue virus VP7 were combined and concentrated and are 
labelled “FX-FX conc”. The sample loaded is labelled and FT is the flow through of protein that did 
not bind the column. The molecular mass marker (marked as “M”) has sizes in kDa, marked on the 
gel. The position of Bluetongue virus VP7 is marked with purple arrows. Purification performed using 
and BioRad NGC™ Chromatography system with ChromLab software (Hercules, USA). Selected data 
used in this Figure was published in Russell and Gildenhuys (2018).  
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Whereas the absorbance reading of the second peak containing the majority of Bluetongue virus 
VP7 is less for NiCo21(DE3) cells which is consistent with the decrease it non-specific bacterial cell 
proteins being eluted along with Bluetongue virus VP7, suggesting that instead of preventing 
binding of non-specific bacterial cell protein completely, the proteins bound less tightly for 
NiCo21(DE3) cells than for BL21(DE3) cells and were thus eluted at a lower imidazole concentration, 
thus explaining the higher absorbance seen for NiCo21(DE3) in the first peak. This can also be seen 
in the difference between Figure 3.4B SDS-PAGE lane F2 and Figure 3.8 B SDS-PAGE lane F2, that 
shows darker bands in Figure 3.8 B SDS-PAGE lane F2 for NiCo21(DE3) cells over BL21(DE3) cells 
that correspond to the sized proteins that have bound along with Bluetongue virus VP7 seen in 
lanes F4 to F8 in Figure 3.4B. 
Less Bluetongue virus VP7 was seen to come through in the buffer wash before elution (flow 
through) for the GE Healthcare Histrap high performance column compared to the Macherey-Nagel 
Protino® Ni-NTA column (Figure 3.8A and B, SDS-PAGE lane FT1), this is consistent with the fact 
that the columns are meeting their binding capacity, as the Macherey-Nagel Protino® Ni-NTA 
column has a much greater amount of non-specific binding.  
This is also seen for BL21(DE3) cells on the two columns (Figure 3.4A and B, SDS-PAGE lane FT1). As 
with BL21(DE3) cells, there was a drastic decrease in non-specific binding of bacterial cell proteins 
on the GE Healthcare Histrap high performance column compared to the Macherey-Nagel Protino® 
Ni-NTA column and therefore the GE Healthcare Histrap high performance columns were used for 
further studies. 
For all purifications, Bluetongue virus VP7 bound the column and was eluted within the imidazole 
gradient. Fractions with high A280 absorbance readings were analysed with SDS-PAGE and fractions 
that were found to contain Bluetongue virus VP7 were then combined and concentrated (Figure 
3.8). Buffers used during purification contained 500 mM sodium chloride to help prevent non-
specific binding. This did not prevent binding but caused the other bacterial cellular proteins to 
bind less tightly and be eluted first at lower imidazole concentrations. Affinity chromatography 
resulted in polyhistidine tagged Bluetongue virus VP7 being eluted with approximate 95 % purity 
as estimated using BioRad Image LabTM software version 6.0.1 (Hercules, USA) Relative Quantity 
tool. The absorbance spectrum of the purified Bluetongue virus VP7 was recorded (Figure 3.9) and 
A280 values were used to obtain protein concentration using equation 1.  
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Figure 3.9. Absorbance spectrum of purified Bluetongue virus VP7 from NiCo21(DE3) cells. 
Stock Bluetongue virus VP7 was scanned from 240-340 nm, yielding the above absorbance 
spectrum. The spectrum was recorded in Primary buffer with 5 M urea, using an Applied 
Photophysics Chirascan Plus (Leatherhead, United Kingdom) at 20 °C. 
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Due to the noise present in the absorbance spectrum produced (Figure 3.9) the protein 
concentration was further confirmed using Bradford assay as described in section 2.8.1.2. The 
concentration was determined to be 16 μM, and therefore approximately 12 mg/250ml cell culture 
of purified Bluetongue virus VP7 was obtained from NiCo21(DE3) cells. 
3.3 C43(DE3) pLysS cells. 
OverExpress™ C43(DE3) pLysS cells were tested, as they are known to be a strain of Escherichia coli 
created by Lucigen, that are efficient at tolerating toxic and membrane proteins from a number of 
different organisms (Miraux and Walker, 1996). Toxic in this sense is any protein that causes 
damage to the cell after expression, which may or may not lead to cell death or a decrease in cell 
growth. C43(DE3) pLysS cells contain genetic mutations that allow a tolerance of and higher 
expression of said proteins. The C43(DE3) pLysS cells carry a chromosomal copy of the T7 RNA 
polymerase gene (Duman-Seignovert et al., 2004). pLysS is a plasmid that contains the T7 lysozyme 
gene (LysS) which is able to interact with T7 RNA polymerase causing the inhibition of protein 
expression until cells are induced by the addition of IPTG. This, combined with delayed expression 
of LacY and T7 RNA polymerase, results in slower induction rates and expression (Wanger et al., 
2008), which can result in a greater production of soluble protein (Weickert et al., 1996). Therefore, 
C43(DE3) pLysS cells were tested because even though Bluetongue virus VP7 is not known to be 
toxic, the slower expression could have potentially resulted in a higher level of soluble expression.  
3.3.1 Expression. 
Protein expression in C43(DE3) pLysS cells were evaluated using three variables, namely (1) post 
induction time (Figure 3.10A), (2) post induction temperature (Figure 3.10B) and (3) inducer 
concentration (Figure 3.10C). 
When post induction expression in C43(DE3) pLysS cells were tested over a time of two to 16 hours 
(Figure 3.10A) SDS-PAGE analysis showed an increase in protein expression corresponding to an 
increase in cell density with increased growth time. Very little expression of Bluetongue virus VP7 
was seen in both the soluble (supernatant) and insoluble (pellet) fractions. The lack of expression 
of Bluetongue virus VP7 was again seen between cells grown at 25 ˚C and 37 ˚C (Figure 3.10B) and 
with different inducer concentrations of 0.1 mM and 1.0 mM IPTG (Figure 3.10C). The main 
overexpressed protein band produced by the C43(DE3) pLysS cells, migrated a distance inconsistent 
with that of Bluetongue virus VP7’s molecular mass of 41 kDa (Figure 3.10D). This was further seen 
when samples from C43(DE3) pLysS, BL21(DE3) and NiCo21(DE3) cells were run on SDS-PAGE 
(Figure 3.10E) which demonstrated that the overexpressed band migrated a distance relating to a 
smaller molecular mass in C43(DE3) pLysS cells than in the other two cell lines.  
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Figure 3.10. Bluetongue virus VP7 expression in C43(DE3) pLysS cells.  
SDS-PAGE of C43(DE3) pLysS cells expression studies depicting whole cell, supernatant and pellet 
samples under varying conditions namely (A) change in post-induction time, (B) change in post-
induction temperature and (C) change in inducer concentration. Expression conditions kept constant 
are indicated above each gel. “WC” is the whole cell, “Sup” is supernatant and “Pe” is pellet samples 
that were obtained and visualised. (D) SDS-PAGE showing differences in size of overexpressed 
proteins found in different cells lines containing the pET28a plasmid with Bluetongue virus VP7 
insert. The positioning of expressed Bluetongue virus VP7 marked with purple arrows.  
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Therefore, we can conclude that very little expression of Bluetongue virus VP7 was seen in either 
the soluble (supernatant) or insoluble (pellet) fractions under all conditions tested (see Figure 3.10). 
C43(DE3) pLysS were therefore not used for further studies. 
3.4 KRX cells. 
Single-Step (KRX) Competent Cells were tested as they are said to provide a tightly controlled 
expression of proteins using a T7 promoter as they contain a chromosomal copy of the T7 RNA 
polymerase controlled by a rhamnose promoter (rhaPBAD) (Hartnett et al., 2006). When rhamnose 
is added it causes T7 RNA polymerase expression, which then results in the transcription of the 
gene of interest under control of the T7 promoter. The rhaPBAD promoter is known to ensure less 
pre-induction basil protein expression than the lac UVS promoter. Lower levels of pre-induction 
protein expression has been linked to higher levels of soluble protein expression (Hartnett et al., 
2006; Wegerer et al., 2008). 
3.4.1 Expression. 
KRX cell’s protein expression was evaluated using three variables, namely (1) post induction time 
(Figure 3.11A), (2) post induction temperature (Figure 3.11B) and (3) inducer concentration (Figure 
3.11C). 
Similarly to section 3.1.1 through SDS-PAGE analysis and construction of calibration curves a size 
41 kDa was obtained for the overexpressed protein, consistent with a size of 38 kDa for Bluetongue 
virus VP7 protein (Basak et al., 1992; Grimes et al., 1995) with both a C and N terminal polyhistidine 
tag and a thrombin cleavage site. This would place the protein in between ovalbumin (45 kDa) and 
lactate dehydrogenase (35 kDa) in the protein marker.  
When KRX cells were evaluated over a post-induction time period between two and 16 hours 
(Figure 3.11A), an increase in protein expression was seen over time with a steady increase 
between two and three, three and four and four and five hours, but very little increase between 
five and 16 hours, however as with BL21(DE3) and NiCo21(DE3) expression of Bluetongue virus VP7 
occurs largely in the insoluble fraction (pellet) and the increase seen over time results in more 
protein in the insoluble fraction (pellet) only. 
KRX cells were grown, after induction, at three temperatures, namely 16 ˚C, 22 ˚C and 37 ˚C (Figure 
3.11B). There was a marked increase in expression of Bluetongue virus VP7 with an increase in 
temperature. This is seen as there is a large increase in expression between 16 ˚C and 22˚C and a 
slightly smaller but still significant increase between 22 ˚C and 37 ˚C. At all three temperatures, 
Bluetongue virus VP7 expression occurred mainly in the insoluble fraction (pellet). 
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Figure 3.11. Bluetongue virus VP7 expression in KRX cells.  
SDS-PAGE of KRX cells expression studies depicting supernatant (Sup) and pellet (Pe) samples for 
(A) change in post-induction time, (B) change in post-induction temperature and (C) change in 
inducer concentration. Expression conditions kept constant are indicated above each gel. The 
supernatant (Sup) and pellet (Pe) samples were obtained and visualised. The position of Bluetongue 
virus VP7 is indicated by purple arrows.  
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Lastly, KRX cells were induced with three inducer concentrations, namely 0.05 %, 0.1 % and 0.15 % 
rhamnose, whilst keeping IPTG concentration constant at 0.1 mM (Figure 3.11C). Bluetongue virus 
VP7 expression was not seen to increase with an increase in inducer concentration with 0.05 % and 
0.1 % concentrations producing similar levels of expression and an apparent decrease in expression 
at the highest concentration of 0.15 %. For 0.05 %, 0.1 % and 0.15 % rhamnose Bluetongue virus 
VP7 expression occurred mainly in the insoluble fraction (pellet). 
BL21(DE3), NiCo21(DE3) and KRX cells appeared to express similar amounts of insoluble Bluetongue 
virus VP7 at 37 ˚C, however, both BL21(DE3) cells and NiCo21(DE3) cells expressed less bacterial 
cell proteins in the insoluble fraction (pellet). The lower concentration of bacterial protein 
expression in the insoluble fraction with Bluetongue virus VP7 along with the fact that NiCo21(DE3) 
cells are specifically engineered to help improve purity obtained from IMAC purification, resulted 
in BL21(DE3) and NiCo21(DE3) cells being used for further studies.  
3.5 Buffer exchange of solubilized protein for further studies. 
Concentrated fractions of purified protein from BL21(DE3) cells (section 3.1.3) and NiCo21(DE3) 
cells (section 3.2.3) were in Equilibration buffer D and approximately 400 mM imidazole after 
purification. In order to study purified Bluetongue virus VP7, changes in buffer conditions were 
required. 
Using dialysis allows for the protein’s environment to gradually change from one set of conditions 
to another. When Bluetongue virus VP7 was dialysed into Primary buffer with 20 mM sodium 
chloride, visible precipitation was seen. When purified Bluetongue virus VP7 was dialysed into 
Primary buffer with 20 % glycerol a small amount of visible precipitation occurred, but disappeared 
with further incubation time. When purified Bluetongue virus VP7 was dialysed into Primary buffer 
with 5 M ultra-pure urea, no visible precipitation occurred. All three conditions were further tested. 
3.6 Protein characterization. 
3.6.1 Clear native PAGE. 
Clear native PAGE protein samples are placed in a buffer that does not contain any reducing or 
denaturing agents resulting in the protein maintaining its secondary, tertiary and quaternary 
structure. Therefore, the protein moves based on its structural conformation as well as its size 
through the gel (Walker, 1994; Arndt et al., 2012). In addition, individual denaturing conditions can, 
therefore, be evaluated, such as boiling and the addition of denaturants. 
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The clear native PAGE results confirm that purified Bluetongue virus VP7 protein occurs in at least 
three forms (lane 1, 7 and 9) however when in the presence of 5 M urea, Bluetongue virus VP7 is 
primarily in a single form (lane 3) (Figure 3.12). Samples in 5 M urea that have been boiled (lane 2) 
and had 2 % SDS added (lane 8) are predominantly in a single form as well. Samples in 8 M urea 
(lane 4) have a similar single form as samples in 5 M urea. Samples in 2 M urea (lane 9) appear to 
have at least three forms, suggestive that 2 M urea is not sufficient to prevent the formation of 
oligomers or aggregates. The three forms seen on the gel are potentially monomer, trimer and 
oligomer, with potentially larger aggregates seen in the loading well, having not entered the gel. 
These potentially larger oligomers are notably greater in samples without urea. However, this may 
just be well staining. Monomer, trimer and oligomer are predicted based on studies by Rutkowskaa 
et al. (2011); Monastyrskaya et al. (1997) and Limn et al. (2000) that found that African horse 
sickness virus VP7 and Bluetongue virus VP7 still displayed trimer on an SDS-PAGE and the ability 
of Rotavirus VP6, a structurally related protein to Bluetongue Virus VP7, to form larger 
macromolecules under certain conditions (Lepault et al., 2001). 
Bluetongue virus VP7 that was boiled and had 2 % SDS added, still showed at least three forms 
(lane7). In 5 % sodium dodecyl sulfate (SDS) there appears to be predominately only two forms of 
Bluetongue virus VP7 (lane 6) with the smaller form having a much greater concentration. In 8 % 
SDS there appears to predominantly be only a single form (lane 5). Bluetongue virus VP7 in the 
presence of 20 % glycerol were not analysed using clear native PAGE as the glycerol interfered with 
the protein’s movement in the gel (data not shown). 
3.6.2 Secondary structural characterization. 
Far-UV circular dichroism was used as a probe to study the secondary structure of purified 
Bluetongue virus VP7 in a number of different buffer conditions. For purified Bluetongue virus VP7 
dialysed into Primary buffer and 5 M urea or 20 % glycerol, the presence of urea and glycerol in the 
buffers used meant that the CD spectra were recorded to approximately 210 nm, as the noise to 
signal ratio was too high below this wavelength, as detected by the dynode voltage. Resulting in 
the spectra being recorded from 210 and 250 nm. 
Bluetongue virus VP7’s published structure contains alpha-helices and beta-strands (Grimes et al., 
1995). The spectrum was anticipated to contain troughs at approximately 218 nm and a peak at 
approximately 196 nm for the beta-strands, and troughs at approximately 222 nm and 208 nm and 
a peak at approximately 190 nm for alpha-helices if the protein still had secondary structure. A 
positive at 212 nm and trough at 195 nm would be seen if 5 M urea had resulted in Bluetongue 
virus VP7 becoming a random coil (Ranjbar and Gill, 2009).  
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Figure 3.12. Clear native PAGE of purified Bluetongue virus VP7. 
Shows clear native PAGE of purified Bluetongue virus VP7 in a BioRad native PAGE sample buffer 
with specific sample conditions marked on the gel below the respective lane. Selected data used in 
this Figure was published in Russell and Gildenhuys (2018). 
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The spectrum produced for Bluetongue virus VP7 in 5 M urea contained negative readings at both 
218 nm and 222 nm, with a slight positive movement towards 210nm (Figure 3.13), which is 
suggestive of a protein that contains both alpha-helices and beta-strands (Ranjbar and Gill, 2009).  
Using the data collected from the spectrum for Bluetongue virus VP7 in Primary buffer with 5 M 
urea, the K2D3 tool of Dichroweb (Louis-Jeune et al., 2011) was used to estimate the percentage 
alpha-helices and beta-strands for Bluetongue virus VP7. The predicted values can be seen in Table 
3.1 as well as the percentages of alpha-helices and beta-strands for Bluetongue virus VP7 obtained 
from a secondary structure server, namely 2Struc (Klose et al., 2010),  for the PDB file 1BVP 
generated from crystallography studies by Grimes et al. (1995). A similar percentage is seen for 
both alpha-helices and beta-strands for the predicted values from the spectrum and those 
predicted from structure produced by Grimes et al. (1995), indicative of correctly folded secondary 
structure in 5 M urea and even in 8 M urea. 
When 1.7 μM Bluetongue virus VP7 in Primary buffer with 20 % glycerol was evaluated using far-
UV CD, the spectrum collected (Figure 3.13) again showed negative readings at both 218 nm and 
222 nm and when studied using K2D3 tool from Dichroweb (Louis-Jeune et al., 2011) it was 
estimated to contain a slightly higher alpha-helical content than Bluetongue virus VP7 in 5 M urea 
(Table 3.1). However, the increase is within a reasonable percentage for slight structural change. 
Far-UV CD spectrum for 1.9 µM Bluetongue virus VP7 in Primary buffer with 6 M guanidinium 
chloride shows a characteristic spectrum of an unfolded protein with more positive ellipticity 
leading up to 212 nm, suggesting that secondary structure is unfolded in 6 M guanidinium chloride. 
3.6.3 Tertiary structural characterization. 
The dominant intrinsic fluorophore is tryptophan, which is extremely sensitive to its environment 
(Eftink, 1994). The consensus sequence of Bluetongue virus VP7 used contains five tryptophan 
residues (Trp119, Trp141, Trp188, Trp225 and Trp278) as seen in Figure 2.1 (Grimes et al., 1995; 
Gasteiger et al., 2005; Russell et al., 2018). The fluorescence spectra obtained for 1.7 μM 
Bluetongue virus VP7 in Primary buffer with 5 M urea established a single peak (λmax) at 341 nm, 
indicative that Bluetongue virus VP7 retains a folded tertiary structure (Figure 3.14) as the λmax is in 
line with the spectra produced by tryptophan in a hydrophobic environment. This peak at 341 nm 
occurred for purified Bluetongue virus VP7 in Primary buffer with 20 mM sodium chloride without 
the presence of urea. The scattering of the excitation wavelength can signify the existence of 
protein precipitation in a protein sample (Lakowicz, 1999). The spectrum for 1.7 μM purified 
Bluetongue virus VP7 in Primary buffer with 20 mM sodium chloride without the presence of urea, 
showed significant scattered light at and around 295 nm (Figure 3.14).  
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Figure 3.13. Circular dichroism spectra of Bluetongue virus VP7.  
Circular dichroism spectra of Bluetongue virus VP7 obtained between 250 and 210 nm for 1.7 μM 
Bluetongue virus VP7 in Primary buffer with 20 mM sodium chloride (   ); 2 M urea (  ); 5 M urea (  ); 
8 M urea (  ); 20 % glycerol (  ) and 1.9 µM Bluetongue virus VP7 in Primary buffer with 6 M 
guanidinium chloride (   ). Selected data used in this Figure was published in Russell and Gildenhuys 
(2018). 
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Table 3.1: Prediction of alpha-helical and beta-strand protein content for Bluetongue virus VP7.  
2Struc secondary structure server (Klose et al., 2010) predicated alpha-helical and beta-strand 
content of Bluetongue virus VP7 monomer and trimer from PDB file 1BVP from Grimes et al. (1995) 
and K2D2 Dichroweb (Louis-Jeune et al., 2011) predicted alpha-helical and beta-strand values using 
far-UV CD spectra (Figure 3.13) of Bluetongue virus VP7 in Primary buffer with 0 M, 2 M, 5 M and 8 
M urea as well as 20 % glycerol. 
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Figure 3.14. Fluorescence emission spectra of Bluetongue virus VP7. 
Fluorescence emission spectra obtained between 500 nm and 280 nm for 1.7 μM Bluetongue virus 
VP7 in Primary buffer with 20 mM sodium chloride (   ); 2 M urea (   ); 5 M urea (   ); (8 M urea (   ); 
20 % glycerol (   ) and 1.9 µM Bluetongue virus VP7 in Primary buffer with 6 M guanidinium chloride 
(   ). Selected data used in this Figure was published in Russell and Gildenhuys (2018).  
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Therefore, it can be deduced that the exclusion of 5 M urea results in Bluetongue virus VP7 forming 
protein aggregates (Figure 3.14).  
This is in agreement with the clear native PAGE results, where more protein forms and a greater 
amount of large oligomers were present when urea was absent from the samples (Figure 3.1, lane 
1). The 1.7 μM purified Bluetongue virus VP7 in Primary buffer with 20 % glycerol produced a single 
peak at 339 nm, and a slight increase in fluorescence intensity showing a similar folded tertiary 
structure as that found in Bluetongue virus VP7 in Primary buffer with 5 M urea (Figure 3.14). This 
is in agreement with findings that glycerol results in a slightly more compact protein structure 
(Gekko and Timasheff, 1981a). Bluetongue virus VP7 in Primary buffer with 6 M guanidinium 
chloride (1.9 µM), shows a decline in fluorescence intensity and a λmax red shift from 341 nm to 355 
nm, showing protein unfolding occurring in 6 M guanidinium chloride (Lakowicz, 1999). 
3.7 Conformational stability.  
3.7.1 Characterization of Bluetongue virus VP7 in the presence of denaturants. 
3.7.1.1 Urea. 
Bluetongue virus VP7 structure was evaluated in Primary buffer with three different concentrations 
of urea, namely 2 M, 5 M and 8 M (Figure 3.13 and Figure 3.14). 
For far-UV CD spectra collected (Figure 3.13), similar troughs are seen at 218 nm and 222 nm for 2 
M, 5 M and 8 M urea, with a decrease in signal seen for 2 M urea presumably due to the protein 
precipitation caused by it being in a lower urea concentration. This is supported by Dichroweb K2D3 
(Louis-Jeune et al., 2011) alpha-helical and beta-strand protein content predictions seen in Table 
3.1, which shows similar alpha-helical contents for Bluetongue virus VP7 in 2 M, 5 M and 8 M urea. 
As for Bluetongue virus VP7 without any urea which is close to the 2Struc (Klose et al., 2010) 
prediction using the PDB file 1BVP from Grimes et al. (1995) of 36.38 % for both monomer and 
trimer. For beta-strand content Bluetongue virus VP7 in 5 M and 8 M urea showed a closer value 
to the 2Struc (Klose et al., 2010) predicted monomer value of 17.19 %. Bluetongue virus VP7 
without urea and in 2M urea shows a beta-strand percentage closer to the 2Struc (Klose et al., 
2010) predicted trimer content at 18.62 %.  
This is consistent with the clear native PAGE (Figure 3.12, lanes 1 and 9) which showed more than 
one form present in the Bluetongue virus VP7 samples without urea and in 2 M urea. That being 
said, even in 8 M urea Bluetongue virus VP7 still has significant secondary structure. 
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For fluorescence (Figure 3.14) a single peak at 341 nm was seen at all three concentrations although 
a slight decrease in fluorescence signal was seen at 295 nm for 8 M urea. Significant light scatter 
was seen in the fluorescence reading for Bluetongue virus VP7 in 2 M urea, consistent with other 
data collected depicting protein precipitation occurring when urea is removed from the protein 
sample. Decrease in fluorescence intensity for Bluetongue virus in 2 M urea is due to the increase 
in protein precipitation, presumably of protein aggregation forming, seen as the scatter around 295 
nm (excitation wavelength), depicting that this concentration is not sufficient enough to prevent 
protein aggregation from occurring. Significant tertiary structure is still seen even when Bluetongue 
virus VP7 is placed into 8 M urea, showing that even 8 M urea does not significantly alter protein 
structure. 
3.7.1.2 Guanidinium chloride. 
Fluorescence and far-UV CD spectra were recorded for purified Bluetongue virus VP7 in Primary 
buffer with 6 M guanidinium chloride (Figure 3.15). The sample was then diluted down to 1 M 
guanidinium chloride to check for refolding. For purified Bluetongue virus VP7 the presence of 
guanidinium chloride resulted in the far-UV CD spectra only being recorded to approximately 214 
nm as the noise to signal ratio was too high below this wavelength, as detected by turbidity (dynode 
voltage). For far-UV CD (Figure 3.15A), there is a substantial loss of secondary structure in 6 M 
guanidinium chloride.  
The ellipticity at 222 nm and 218 nm was used to evaluate the recovery of secondary structure as 
these are signature troughs in a protein containing both beta-strands and alpha-helices. Refolded 
Bluetongue virus VP7 (Figure 3.15 A) shows a 94 % recovery at 218 nm and an 89 % recovery at 222 
nm. Thus the equilibrium unfolding transition cannot be further analysed to determine 
thermodynamic parameters. 
As seen in Figure 3.15B, at 6 M guanidinium chloride there is a distinct peak at 355 nm, suggesting 
an unfolded protein.  After diluting to 1 M guanidinium chloride the peak returns to 342 nm, 
suggesting a refolded protein. However, the fluorescence intensity differences due to different 
protein concentrations caused by dilution for refolding studies prevents percentage recovery 
values from being obtained as fluorescence intensities cannot be concentration corrected as the 
signal is not linearly dependent on protein concentration. There is an increase in light scatter at 
295 nm, suggesting an increase in protein precipitation that occurs during refolding when not in 
the presence of urea or glycerol (Figure 3.14).  
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Figure 3.15. Bluetongue virus VP7 in presence of guanidinium chloride. 
(A) Far-UV CD Spectra between 250 nm and 214 nm for Bluetongue virus VP7 in Primary buffer (  ) 
at 1.9 µM, Primary buffer with 6 M guanidinium chloride (   ) at 1.9 µM and 1 M guanidinium chloride 
(  ) at 1 µM (B) Fluorescence emission spectrum between 450 nm and 285 nm for purified Bluetongue 
virus VP7 (not concentration corrected) in Primary buffer with 6 M guanidinium chloride (1.9 μM)   
(  ), and when allowed to refold in 1 M guanidinium chloride (1.0 μM) (   ). (C) Shows λmax fluorescence 
values ( ), far-UV CD 218 nm values ( ) and 222 nm values ( ) at several guanidinium chloride 
concentrations.  
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Figure 3.15C shows λmax fluorescence values and mean residue ellipticity values at 218 nm and 222 
nm for samples from 0 M to 6 M guanidinium chloride, showing cooperative unfolding of the 
secondary and tertiary structure. The λmax shifting from 341 nm for Bluetongue virus VP7 without 
the presence of guanidinium chloride to 355 nm in 6 M guanidinium chloride, with significant 
structural unfolding from 3 M guanidinium chloride. The increase in mean residue ellipticity at both 
218 nm and 222 nm indicate similar cooperative unfolding of both alpha-helices and beta-strands, 
showing significant structural changes occurring from 3 M guanidinium chloride.  
3.7.2 Thermal-induced unfolding. 
3.7.2.1 Spectroscopic studies. 
Far-UV CD was used as a secondary structure stability probe when heating the protein from 20 ˚C 
to 90 ˚C in two different buffers, namely Primary buffer with 5 M urea and Primary buffer with 20 
% glycerol (Figure 3.16). Thermal stability of Bluetongue virus VP7 was tested at three different 
concentrations, namely 1.0 μM, 1.4 μM and 1.7 μM in the Primary buffer with 5 M urea and at a 
concentration of 1.0 μM in Primary buffer with 20 % glycerol. A far-UV CD spectrum for the thermal 
unfolding of protein in Primary buffer with 20 mM sodium chloride, was not obtainable as the noise 
to signal ratio was too low.  
The characteristic troughs for a protein that contains both alpha-helices and beta-strands are 208 
nm, 218 nm and 222 nm (Ranjbar and Gill, 2009), however the signal to noise ratio was best at 218 
nm and 222 nm due to the presence of urea and glycerol in the samples, and therefore these 
wavelengths were used as secondary structural probes and not the signal at 208 nm.  All the 
samples demonstrated secondary structural changes consistent with protein unfolding as the 222 
nm and 218 nm ellipticity values increased when the temperature was increased (Figure 3.16A, B 
and D), shifting towards the characteristic far-UV spectrum of a random coil with a positive peak at 
212 nm and trough at 195 nm (Ranjbar and Gill, 2009).  
The three different concentrations of Bluetongue virus VP7 (1.0 μM, 1.4 μM and 1.7 μM) showed 
little change in ellipticity for 218 nm and 222 nm between 20 ˚ C and 55 ˚ C (Figure 3.16A), suggesting 
minor structural reorganization rather than a major conformational change up until this 
temperature. Significant secondary structure loss is then seen from approximately 55 ˚ C, with some 
secondary structure still seen to remain even at 90 ˚C, as the spectrum at 90 ˚C is not fully 
characteristic of a random coil (Figure 3.16B) (Ranjbar and Gill, 2009) and the unfolding curves have 
not reached a plateau in Figure 3.16A. The spectra for protein refolding after heating (Figure 3.16 
B and D) depicts that protein unfolding is irreversible for Bluetongue virus VP7 in Primary buffer 
with 5 M urea and 20 % glycerol. 
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Figure 3.16. Far-UV circular dichroism monitoring of thermal unfolding of Bluetongue virus VP7. 
(A) Heat unfolding curves using far-UV CD values at 218 nm and 222 nm wavelengths between 20 
˚C and 90 ˚C, for Bluetongue virus VP7 in Primary buffer with 5 M urea at three different 
concentrations namely, 1 µM (218 nm   , 222 nm    ), 1.4 µM (218 nm    , 222 nm    ) and 1.7 µM (218 
nm    , 222 nm   ) and Bluetongue virus VP7 in Primary buffer with 20 % glycerol (218 nm    , 222 nm 
b  ) at a concentration of 1 µM. (B) Far-UV CD spectrum between 20 ˚C and 90 ˚C (dark blue to dark 
red) for Bluetongue virus VP7 in Primary buffer with 5 M urea. Protein refolding after heating shown 
in black. (C) Turbidity (dynode voltage) plots Bluetongue virus VP7 in Primary buffer with 5 M urea 
at 218 nm (   ) 222 nm (   ). (D) Far-UV CD spectrum between 20 ˚C and 90 ˚C (dark blue to dark red) 
for Bluetongue virus VP7 in Primary buffer with 20 % glycerol. Protein refolding after heating shown 
in black. Selected data used in this Figure was published in Russell and Gildenhuys (2018). 
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The similar unfolding transitions seen for all three protein concentrations is indicative of a single 
species of monomeric protein being present in the protein sample. This is because oligomeric 
protein stability has been seen to increase with an increase in protein concentration, as protein-
protein interactions in addition to the protein structure itself, needs to be disrupted (Steif et al., 
1993; Salminen et al., 1996; Shriver and Edmondson, 2009). This finding is consistent with clear 
native PAGE findings (Figure 3.12) that show that in the presence of 5 M urea, Bluetongue virus 
VP7 is present predominantly in a single form. 
Bluetongue virus VP7 in the presence of 20 % glycerol showed a different unfolding transition with 
a significant loss in secondary structure from approximately 52 ˚C, suggesting a destabilisation of 
the structure in comparison to Bluetongue virus VP7 in 5 M urea. That being said, there was 
significantly more secondary structure remaining at 90 ˚C for Bluetongue virus VP7 in 20 % glycerol 
when compared to Bluetongue virus VP7 in 5 M urea, showing a less cooperative nature of 
unfolding in the presence of 20 % glycerol. Limitations of the instrument, being unable to record 
data from a sample that is being boiled, resulted in the inability to record the full unfolding 
transition.  
Figure 3.16C shows a turbidity (dynode voltage) plot indicating aggregation occurring as protein 
unfolds with increasing temperature. The drop in readings between 70 ˚C and 80 °C could be due 
to precipitation of protein aggregates before a further spike in aggregation formation between 80 
˚C and 90 °C. 
Intrinsic fluorescence from the aromatic amino acid tryptophan is sensitive to the polarity of the 
amino acid’s immediate environment (Teale, 1960; Longworth, 1971; Lakowicz, 1999), which 
creates a valuable technique to study protein unfolding, as the fluorescence spectrum changes, the 
tryptophan residue moves from the hydrophobic environment of a folded protein to the 
hydrophilic environment of an unfolded protein (Teale, 1960; Gryczynski et al., 1988a; Gryczynski 
et al., 1988b; Lakowicz, 1999). The emission of several proteins that contain tryptophan residues 
caused a reduction in fluorescence intensity and a red shift in λmax when unfolded (Teale, 1960).  
Fluorescence monitored unfolding of Bluetongue virus VP7 was undertaken in three different 
buffers, namely Primary buffer with 5 M urea, Primary buffer with 5 M urea and 300 mM sodium 
chloride and Primary buffer with 20 % glycerol as seen in Figure 3.17.  All samples showed a decline 
in fluorescence intensity and a slight shift in λmax to a longer wavelength with an increase in 
temperature (Figure 3.17B and C and D).  
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Figure 3.17. Fluorescence monitored thermal unfolding of Bluetongue virus VP7. 
(A) Heat unfolding curve for 341 nm fluorescence readings from 20 ˚ C to 90 ˚ C for 1.4 μM Bluetongue 
virus VP7 in Primary buffer with 5 M urea (   ), and 1 µM Bluetongue virus VP7 in Primary buffer with 
5 M urea, 300 mM sodium chloride (  ) and 339 nm for 1.0  µM Bluetongue virus VP7 in Primary 
buffer with 20 % glycerol (  ). The spectrum between 450 nm and 310 nm between 20 ˚C and 90 ˚C 
(dark blue to dark red) for: (B) 1.7 μM Bluetongue virus VP7 in Primary buffer with 5 M urea. (C) 1.0 
μM Bluetongue virus VP7 in Primary buffer with 5 M urea and 300 mM sodium chloride. (D) 1.0 μM 
Bluetongue virus VP7 in Primary buffer with 20 % glycerol. Protein refolding after heating shown 
black for each sample. Selected data used in this Figure was published in Russell and Gildenhuys 
(2018). 
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This is consistent with tertiary structure changing in a protein that is unfolding, as the altered 
emission results from tryptophan residues moving from a hydrophobic to a hydrophilic 
environment as they become exposed as the protein unfolds (Teale, 1960; Gryczynski et al., 1988a; 
Gryczynski et al., 1988b; Lakowicz, 1999). The decline in fluorescence intensity could also partially 
be due to thermal quenching as the quantum yield of a chromophore is dependent on temperature 
and is known to decrease with an increase in temperature (Demchenko, 1986).  
For Bluetongue virus VP7 in Primary buffer with 5 M urea, a reduction in intensity was seen and a 
λmax red shift from 341 nm to approximately 348 nm. For Bluetongue virus VP7 in Primary buffer 
with 20 % glycerol, the λmax shifted from 339 nm to approximately 343 nm and Bluetongue virus 
VP7 in Primary buffer with 5 M urea with 300 nm sodium chloride showed a λmax shift from 341 nm 
to 345 nm. The heat unfolding curve for Bluetongue virus VP7 in 5 M urea at 341 nm (Figure 3.17A) 
shows slight changes in structure until approximately 68 ˚C, after which there are major structural 
changes occurring until at least 90 ˚ C. The heat unfolding curves for Bluetongue virus VP7 in Primary 
buffer with 20 % glycerol at 339 nm and Primary buffer with 5 M urea with 300 mM sodium chloride 
at 341 nm (Figure 3.17A) shows that there are only slight structural changes until approximately 85 
˚C, after which there are more prominent structural changes. Limitations of the instrument, being 
unable to record data from a sample that is being boiled, again resulted in the inability to record 
the full unfolding transition. 
At 90 ˚C the emission maximum for Bluetongue virus VP7 in 5 M urea, 20 % glycerol and 5 M urea 
with 300 mM sodium chloride was found to be 348 nm, 343 nm and 345 nm respectively, suggesting 
that complete exposure of tryptophan to an aqueous medium does not occur at this temperature 
(Lakowicz, 1999). The fluorescence intensity also decreased to a lesser extent for Bluetongue virus 
VP7 in the presence of 20 % glycerol (without urea) and 300m M sodium chloride (with 5 M urea) 
when compared to Bluetongue virus VP7 in 5 M urea. Along with smaller λmax shift, this shows an 
increase in tertiary structure stability when Bluetongue virus VP7 is in sodium chloride or glycerol. 
Both of which are known substances for increasing protein stability and the preserved structure in 
these conditions is indicative of their protective function in proteins (von Hippel and Schleich, 1969; 
Gekko and Timasheff, 1981a; Gekko and Koga, 1983; Cleland and Wang, 1990). 
Thermal unfolding was found to be irreversible as the fluorescence and far-UV CD spectra of the 
cooled protein sample did not return to the same values as those for the protein prior to being 
heated to 90 ˚C (black line in Figure 3.16B and D and Figure 3.17B, C and D). 
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The most common cause of irreversible unfolding of heated protein samples is aggregation 
(Benjwal et al., 2006). The turbidity (dynode voltage) recorded during CD experiments can be used 
as an indicator of the level of aggregate formation as the protein is unfolding via increasing heat. 
Thermal unfolding of Bluetongue virus VP7 showed an increase in aggregation depicted by an 
increase in turbidity with the increase in temperature (Figure 3.16C). Therefore the likely cause of 
the irreversibility of the thermal unfolding of Bluetongue virus VP7 is the heat-induced aggregation 
during unfolding. The irreversibility of the thermal unfolding of Bluetongue virus VP7 prevents 
further thermodynamic analysis. 
3.7.2.2 Differential scanning calorimetry. 
The Bluetongue virus VP7 thermogram (Figure 3.18) that is baseline subtracted and corrected, 
revealed a single peak with a maxima value at approximately 353 K (80 ˚C). The thermogram shows 
the start of protein structural alteration after 42 ˚C with the increase in heat capacity, and protein 
structural changes still occurring until at least 100 ˚C. This is consistent with the spectroscopic 
analysis of the thermal unfolding of Bluetongue virus VP7 (Figure 3.16 and 3.17), which showed the 
unfolding transition was not completed at 90 ˚C. Spectroscopic analysis of Bluetongue virus VP7 
confirmed the irreversibility of protein unfolding and therefore further thermodynamic analysis 
could not be undertaken.  
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Figure 3.18. DSC thermogram of the unfolding of Bluetongue virus VP7. 
Thermogram for 1 μM Bluetongue virus VP7 in Primary buffer with 5 M urea, monitored from 10 ˚C 
to 100 ˚C. TA Instruments Nano Differential scanning calorimeter (New Castle, Delaware), was used 
with DSCRun software version 4.4.25 and data collected was analysed using NanoAnalyze version 
3.7.5.  
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4. Discussion. 
Several recombinant bacterial expression systems were tested under multiple different expression 
conditions in order to obtain the most appropriate system for optimal protein production in 
bacterial cells. The recombinant expression systems consisted of the pET28a plasmid with the 
consensus sequence for Bluetongue virus VP7 gene insert transformed into Escherichia coli 
BL21(DE3), NiCo21(DE3), C43(DE3) pLysS and KRX cells. Bluetongue virus VP7 protein was 
predominantly expressed in bacterial inclusion bodies, resulting in insoluble protein under all 
conditions tested (media compositions, post induction temperatures, post induction times and 
inducer concentrations) in all four Escherichia coli strains with little expression occurring in 
C43(DE3) pLysS at all (Figure 3.1, Figure 3.6, Figure 3.10 and Figure 3.11).  
As stated in section 1.7, little is understood about the formation of insoluble inclusion bodies in 
bacterial cells (Villaverde and Carrio, 2003). However, studies have shown that expression 
conditions (including inducer concentration, post induction time and temperature) (Chalmers et 
al., 1990; Neubauer et al., 1992; Van den Berg et al., 1999) as well as the primary sequence of the 
expressed protein (Chiti et al., 2003; Dubay et al., 2004) affect the likelihood of the formation of 
insoluble inclusion bodies. These factors have been linked to the metabolic burden placed on the 
bacteria cells during expression. 
The metabolic burden is the use of the host cells energy and raw materials for the expression of 
the foreign proteins. The amino acid sequence can affect the metabolic burden placed on the cell 
as it has been found that tryptophan, phenylalanine, tyrosine, histidine and methionine have the 
highest energetic costs of all amino acids during their production (Akashi and Gojobori, 2002). 
Bluetongue virus VP7 has a 1.4 % tryptophan, 3.8 % phenylalanine, 2.4 % tyrosine, 4.6 % histidine 
and 5.1 % methionine (Russell et al., 2018), resulting in close to 20 % of the entire protein being 
composed of the highest energy costing amino acids. 
Lessening metabolic burden on bacterial cells during recombinant protein expression is a 
complicated exercise, as it is determined by multiple factors including plasmid copy number, 
promoters used, growth conditions including temperature, aeration and inducer concentrations as 
well as the protein sequence being expressed (Chalmers et al., 1990; Neubauer et al., 1992; Van 
den Berg et al., 1999; Chiti et al., 2003; Dubay et al., 2004). Strategies that have been implemented 
in the past to try to reduce the metabolic burden have included a number of genetic modifications, 
including alterations of transport systems and gene knockouts (Chou et al., 1994; De Anda et al., 
2006).  
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The other approach adopted is the media composition. Media compensation for metabolic burden 
is not an easy task as different proteins respond very differently to media additives (Lourenco et 
al., 2011). Commonly used tactics include amino acid supplementation (Harcum et al., 1992), 
limiting acetate accumulation and control of the growth rates through feeding strategies and 
controlling biomass (Gregory and Turner, 1993; Turner et al., 1994). However, these often only 
solve single problems such as limitation of building blocks and toxicity generation, while sufficient 
energy generation by the bacterial cells still remains an issue (Carneiro et al., 2013). All strategies 
that have been identified have been found to produce temperamental effectiveness that is 
dependent on the protein itself (Carneiro et al., 2013), often requiring extensive trial and error. 
This study found that changes in expression conditions and cell lines, did not significantly affect the 
expression of soluble Bluetongue virus VP7, and instead just influenced the amount of insoluble 
protein expressed (Figure 3.1, Figure 3.6, Figure 3.10 and Figure 3.11). The fact that Bluetongue 
virus VP7 is expressed in the soluble fraction in both insect cells and mammalian cells (Oldfield et 
al., 1990; Hosamani et al., 2011, Bouet-Cararo et al., 2014) suggests that the protein may be 
adapted to being expressed in these cells as they are the host cells for the virus. A logical suggestion 
would be that Bluetongue virus VP7 requires post-translational modification, however no evidence 
has been found of this and the fact that it is still expressed in low concentrations in the soluble 
fraction in Escherichia coli, suggests that it does not require modification (Figure 3.1, Figure 3.6, 
Figure 3.10 and Figure 3.11). Rotavirus VP6, which is structurally very similar to Bluetongue virus 
VP7 has been shown to be extremely reactive to buffer conditions such as pH, salts present and 
ionic strength, with changes in these conditions resulting in changes in protein structure and 
interactions (Lepault et al., 2001). Therefore potentially slight differences in cell conditions could 
greatly influence expression, affecting soluble and insoluble expression in different cell types.  
Another interesting point would be the natural aggregation of viral proteins in viroplasms, which 
are inclusion bodies that form inside infected cells to house viral proteins during virus replication 
(Netherton and Wileman, 2011). The viroplasm production occurs to help increase the efficiency 
of replication as it concentrates components needed such as viral genome, viral proteins and any 
host proteins in close proximity, that are needed in the replication process (Netherton and 
Wileman, 2011). Viroplasm formation can help protect the cell from any potentially toxic proteins 
being expressed during replication, as well as helping to prevent an immune reaction (Wileman, 
2007). This suggests that viral proteins are naturally adapted to aggregating together in a small area 
during replication. 
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Rotavirus, a related Reoviridae virus is known to form viroplasms during replication (Patton et al., 
2006), therefore potentially, Bluetongue viral proteins may share a similar mechanism, which 
would help explain the apparent formation of inclusion bodies around correctly folded Bluetongue 
virus VP7 in bacterial cells. 
Bluetongue virus VP7 predominantly being expressed in the bacterial cell inclusion bodies resulted 
in the need for solubilisation before purification could be undertaken. For Bluetongue virus VP7 
solubilisation was achieved using lower urea concentrations with a freeze-thaw step for efficient 
solubilisation. In Qi et al. (2015) it was found that 2 M urea was the optimal urea concentration 
used to solubilize a number of proteins, as the amount of solubilisation in 2 M urea with a freeze-
thaw step was comparable to solubilisation in 8 M urea without a freeze-thaw step (Qi et al., 2015). 
However, for Bluetongue virus VP7 there was a notable decrease in solubilisation with 2 M urea 
from 5 M urea, but no notable increase in solubilisation from 5 M urea to 8 M urea as seen in Figure 
3.2B and 3.7B.  
Walther et al. (2013) described solubilisation of inclusion bodies resulting from pore-like structures 
forming in the amyloid-like fibrous outer layer of the inclusion body vesicle and that the size and 
number of pores formed is dependent on the solubilisation method used, but that generally there 
is an increase in the quantity and diameter of pores with an increase denaturant concentration. 
Therefore, for this method of solubilisation of Bluetongue virus VP7 we would expect the main role 
of urea at the lower concentrations to be the physical separation of the protein molecules by 
disturbing hydrophobic interactions, and the main force of solubilisation to come from the stress 
of the low temperature and the physical ice crystals that form during freezing that cause 
“punctures” in the inclusion body structure to create the needed pores (Clark, 1998; Qi et al., 2015).  
The physical separation of the proteins is important for them to fit through the pores, and therefore 
provide more efficient solubilisation as more protein is able to be released from the inclusion 
bodies. Urea binding to proteins has been found to be concentration dependent, which often 
results in the need for high concentrations of urea to ensure sufficient binding to effectively interact 
with the proteins (Muralidhara and Prakash, 2001). This is in agreement with results seen in Figure 
3.14 which show significant protein precipitation, as seen in the light scatter around 295 nm in the 
fluorescence spectrum of Bluetongue virus VP7 in 2 M urea, similar to the spectrum produced in 
the sample without any urea, suggesting that 2 M urea is not sufficient to physically separate the 
Bluetongue virus VP7 molecules from one another. This is supported by the clear native PAGE gel 
(Figure 3.12) which shows at least three forms present in the samples without urea and 
predominantly only a single form in samples with 5 M urea.  
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Furthermore, the fluorescence spectrum of Bluetongue virus VP7 in 5 M urea showed very little 
light scatter around 295 nm suggesting that 5 M urea is significantly more effective at separating 
the Bluetongue virus VP7 molecules, and hence why there is the increase in solubilisation seen 
between 2 M and 5 M urea. There was  no further increase in solubilisation from 6 M to 8 M Figure 
3.2B and 3.7B and the slight decrease in fluorescence from 5 M urea to 8 M urea (Figure 3.14) 
resulting from either quenching or slight change in tertiary structure as the λmax doesn’t change, 
suggesting very little  structural change has occurred locally around the tryptophans. It has been 
seen that even at high denaturant concentrations intermolecular and intramolecular interactions 
have been known to occur (Bhavesh et al., 2001). 
Using lower denaturant concentrations for solubilisation of bacterial cell inclusion bodies is 
advantageous because the use of milder solubilisation conditions can help improve the retrieval of 
native protein when compared to solubilisation using higher concentrations of denaturants (Khan 
et al., 1998; Patra et al., 2000; Umetsu et al., 2005). This is not an uncommon occurrence as proteins 
inside bacterial cell inclusion bodies have been shown to still contain native-like secondary 
structures (Przybycien et al., 1994; Ami et al., 2006). Furthermore, freezing-induced separation of 
multimeric proteins has been observed, with said proteins still maintaining native-like secondary 
structure even in an alkaline pH and low concentrations of urea (Stancel and Deal, 1969; Nema and 
Avis, 1993; Pikal-Cleland, 2000). Studies have found that inclusion bodies may enclose properly 
folded proteins stored inside the ‘vesicle sacks’ (Jevsevar et al., 2005; Peternel et al., 2008a; 
Peternel et al., 2008b). 
This appears to be the case for Bluetongue virus VP7, as recombinant protein characterization after 
solubilisation and purification reveals a native-like secondary structure and a folded tertiary 
structure even in the presence of 5 M urea as seen in Figure 3.13 and 3.14. This was supported by 
the predicted alpha-helical and beta-strand percentages made using the K2D3 tool of Dichroweb 
(Louis-Jeune et al., 2011) that indicated a very similar percentage for alpha-helices and beta-strands 
that is contained in a natively folded Bluetongue virus VP7 molecule obtained from Grimes et al. 
(1995). This is further supported by the unfolding of Bluetongue virus VP7 in guanidinium chloride, 
which when diluted from 6 M to 1 M (Figure 3.15), the λmax value shifted from 355 nm to 342 nm, 
with Bluetongue virus VP7 in 1 M guanidinium chloride showing a λmax very similar to Bluetongue 
virus VP7 in urea (341 nm). However, displaying significant light scattering at 295nm, like 
Bluetongue virus VP7 when not in the presence of urea or glycerol. (Figure 3.14 and 3.15 B). 
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The single peak at 341 nm for Bluetongue virus VP7 in 5 M urea and 339 nm in 20 % glycerol (Figure 
3.14) is indicative of a tryptophan residue emission spectra in hydrophobic surroundings, indicating 
the Bluetongue virus VP7 is folded and contains tertiary structure (Lakowicz, 1999).  
Furthermore, the folded structure of Bluetongue virus VP7 in 5 M urea and 20 % glycerol are similar, 
suggesting that the inclusion bodies formed during expression may contain properly folded protein. 
Therefore 5 M urea does not significantly alter Bluetongue virus VP7’s structure which has been 
seen in Basak et al. (1996), who reported that VP7 in Orbiviruses retains its structure in 8 M urea. 
Urea, therefore, helps avoid the development of larger oligomers or aggregates, this is essential in 
the solubilisation and subsequent purification but does not significantly denature the protein 
structure. 
The protein’s stability is further demonstrated by its ability to maintain significant secondary and 
tertiary structure to at least 55 ˚C even in the presence of 5 M urea when probed with far-UV CD 
and intrinsic fluorescence as seen in Figure 3.16 and 3.17. In far-UV circular dichroism, the spectrum 
shifted from troughs indicating a protein containing beta-strands (218 nm) and alpha-helices (222 
nm) to a spectra more characteristic of a random coil as the protein was heated to 90 ˚C (Figure 
3.16). A buried tryptophan has a λmax of around 335 nm, whereas a tryptophan in a hydrophilic 
environment has a λmax around 355 nm, depicting an unfolded protein (Teale, 1960; Gryczynski et 
al., 1988a; Gryczynski et al., 1988b; Lakowicz, 1999). Often the fluorescence intensity decreases, 
and λmax shifts to longer wavelengths when a protein unfolds (Lakowicz, 1999). These shifts are seen 
with Bluetongue virus VP7 as it is heated from 20 ˚C to 90 ˚C, showing significant stability until 
approximately 55 ˚C and irreversible unfolding when heated to 90 ˚C.  
The λmax values at 90 ˚C are 348 nm, 343 nm and 345 nm for Bluetongue virus VP7 in 5 M urea, 20 
% glycerol and 300 mM sodium chloride with 5 M urea respectively, and is suggestive that the 
protein unfolding transition is not complete at 90 ˚C and that significant tertiary structure remains, 
especially when compared to Bluetongue virus VP7 unfolding in 6 M guanidinium chloride (Figure 
3.15B and C), which shows a shift in λmax to 355 nm, a characteristic of a denatured protein (Teale, 
1960; Gryczynski et al., 1988a; Gryczynski et al., 1988b; Lakowicz, 1999). This is further supported 
by the thermogram (Figure 3.18) of Bluetongue virus VP7 in 5 M urea when heated between 10 ˚C 
and 100 ˚C, which showed the unfolding transition occurred until at least 100 ˚C. The smaller shift 
in λmax and fluorescent intensity decreases caused by temperature increases are indicative of 
increased tertiary structure stability of Bluetongue virus VP7 when the protein sample is heated to 
90 ˚C in glycerol (without urea) or sodium chloride (with 5 M urea) (Figure 3.17).  
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Glycerol is a viscous osmolyte and is well known for increasing protein stability during both thermal 
and chemical denaturation, as well as prevention of protein aggregation during protein refolding 
(Jarabak et al., 1966; Jarabak, 1972). The exact molecular mechanism of glycerol increasing protein 
stability is unknown, however glycerol has been seen to alter the native structure of a protein to a 
more compacted state (Gekko and Timasheff, 1981a; Gekko and Timasheff, 1981b), this is seen in 
Figure 3.14, with slight shift in λmax from 341 to 339 nm and a slight increase in fluorescence 
intensity seen for the same protein concentration between Bluetongue virus VP7 in 5 M urea and 
20 % glycerol.  
The prevention of protein precipitation when dialysing in a solution containing glycerol is 
predominantly due to the glycerol changing the viscosity of the protein environment, with the 
higher viscosity (surface tension) likely blocking protein molecule interactions and thus preventing 
protein precipitation (Ou et al., 2002). The protective nature of glycerol against protein aggregation 
and denaturation is dependent on the concentration of glycerol in the solution, with an increase in 
glycerol most often resulting in an increase in protein stability (Ou et al., 2002; Ruan et al., 2003). 
Studies have shown that glycerol molecules do not often bind the protein themselves, but instead 
change water tension around the protein preventing the hydrophobic regions of the protein from 
becoming exposed and resulting in proteins being preferentially hydrated around their surface, 
which increases the free energy needed to denature it (Schachman and Lauffer, 1949; Gekko and 
Timasheff, 1981a; Gekko and Timasheff, 1981b; Timasheff, 1993; Ruan et al., 2003).  
Similarly, sodium chloride acts as a weak kosmotrope, as it contributes to the stability and structure 
of water-water interactions, creating favourable interactions that result in the stabilization of 
intermolecular interactions in proteins (von Hippel and Schleich, 1969). Kosmotropic co-solvents 
such as sodium chloride, interact with the water molecules instead of the protein molecules 
themselves, resulting in preferential hydration much like glycerol (Arakawa and Timasheff, 1982). 
The preferential hydration results in net repulsion between protein and solvent, resulting in protein 
molecules compacting to reduce total surface area exposure, this then leads to an increase in 
hydrophobic aggregation, which increases the Gibbs free energy needed to denature the protein 
(Schachman and Lauffer, 1949; Gekko and Timasheff, 1981a; Gekko and Timasheff, 1981b; 
Timasheff, 1993). Sodium chloride, much like glycerol, stabilized the protein structure despite not 
interacting directly with the protein (Galinski et al., 1997; Soderlund et al., 2003).  
In contrast, guanidinium chloride and urea are chaotropes, meaning they can disrupt the network 
of hydrogen bonds between water molecules, and therefore are able to weaken the stability of the 
protein’s structure by weakening the hydrophobic effect (Salvi et al., 2005). 
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When Bluetongue virus VP7 was studied in the presence of guanidinium chloride, which is well 
known for being a stronger denaturant then urea (Green and Pace, 1974; Pace, 1986), the 
fluorescence spectra (Figure 3.15C) revealed a shift in λmax from 341 nm without guanidinium 
chloride to 355 nm in the presence of 6 M guanidinium chloride, which is the characteristic red shift 
seen in many proteins when unfolding (Lakowicz, 1999). The unfolding reaction appeared to be 
reversible by the λmax shifting back to 342 nm when the sample was diluted back to 1 M guanidinium 
chloride. The far-UV CD spectrum of Bluetongue virus VP7 in guanidinium chloride (Figure 3.15C) 
supported the unfolding of the protein’s secondary structure at 6 M guanidinium chloride. As the 
spectra takes on the characteristics of a random coil, the ellipticity becomes more positive and 
again displayed characteristics of reversibility as ellipticity decreased as the protein solution was 
diluted back to 1 M guanidinium chloride, however, the percentage reversibility was not high 
enough to do further analysis. When Bluetongue virus VP7 was studied in the presence of urea very 
little structural (either secondary or tertiary) change was seen for Bluetongue virus VP7 between 
samples without urea and samples containing up to 8 M urea (Figure 3.13 and 3.14). 
This is not the first time where one denaturant is more efficient than another at unfolding a protein. 
The mechanism of denaturation becomes very important here, however it must be noted that the 
exact molecular mechanism for protein denaturation by either guanidinium chloride or urea is still 
not fully understood, but rather deductions have been made from experimental data and 
denaturant simulations (Camilloni et al., 2008). Two proposed mechanisms involve the direct 
interaction of the denaturant with the protein and the indirect alteration of the solvent 
environment with resultant interruption of hydrophobic interactions as urea or guanidinium 
chloride in water causes the surface tension of the solution to increase (Schellman, 1955; Frank and 
Franks, 1968; Bennion and Daggett, 2003; Camilloni et al., 2008). 
The dissimilarities seen in the capacity of urea and guanidinium chloride to denature proteins has 
been largely attributed to their differential interactions with the protein (Robinson and Jencks, 
1965; Tanford, 1970; Makhatadze and Privalov, 1992). Two of the most important differences 
found between urea and guanidinium chloride is that urea is known to readily form hydrogen bonds 
to polarized areas of charge, such as the peptide backbone, disrupting native intermolecular bonds 
and interactions (Schellman, 1955; Frank and Franks, 1968; Prakash et al., 1981), whereas 
guanidinium chloride does not. Guanidinium chloride instead is attracted to the peptide backbone 
and aromatic protein side chains where it causes disruption of hydrophobic interactions, including 
shielding the unfavourable increase of interaction with water molecules as the protein unfolds 
(Parui et al., 2016). 
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Also significant is the ionic nature of guanidinium chloride, as the charge that the chloride and 
guanidinium ions carry enables it to screen for favourable intermolecular and intramolecular 
electrostatic interactions that may help stabilize or destabilize the protein’s structure and 
therefore, reduction or elimination of these electrostatic interactions can promote the unfolded 
protein form (Tanford, 1970; Greene and Pace, 1974; Pace, 1986; Monera et al., 1994). 
Interestingly, low concentrations of urea and guanidinium chloride are capable of stabilizing certain 
proteins. Urea acts as a weak kosmotrope is some cases, that is it increases the stability of water-
water interactions, creating favourable interactions for protein stability (von Hippel and Schleich, 
1969; Vanzi et al., 1998), whereas guanidinium chloride is able to neutralise destabilizing 
electrostatic interactions (Monera et al., 1994; Bhuyan, 2002; Povarova et al., 2010). However, at 
higher concentrations, the binding of guanidinium ions favours and therefore promotes 
destabilization of the protein structure (Tanford, 1970; Greene and Pace, 1974; Pace, 1986). 
Similarly, the preferential interaction of urea with the protein increases with concentration 
increases, resulting in destabilisation of the protein structure (Prakash et al., 1981). 
Once the process of destabilization of the protein has begun, it then increases exponentially if the 
unfolding is cooperative, this is believed to occur as urea and guanidinium chloride display 
preferential interaction with proteins, meaning that the denaturant molecules have an attraction 
to the protein surface and therefore bind or interact with the protein surface, including peptide 
bonds (Robinson and Jencks, 1965; Tanford, 1970; Prakash et al., 1981). As the protein then unfolds 
more protein surface area becomes exposed, and therefore the ability of the denaturant to bind to 
and interact with the protein increases (Pace, 1986). 
Another important difference seen is that urea appears to destabilize beta-strand structures first, 
whereas guanidinium chloride appears to destabilize alpha-helical structures first (Camilloni et al., 
2008). The extent to which guanidinium chloride is able to be more efficient than urea at unfolding 
a protein has been found to be dependent on the protein’s primary sequence as well as the 
protein’s secondary and tertiary structure. It has been shown that guanidinium chloride is most 
efficient at destabilizing proteins in which electrostatic interactions are important in protein 
structure (Monera et al., 1994) and the planar amino acid side chains within the protein of interest 
play a large role in alpha-helical stability (Dempsey et al., 2005).  
This is further verified through the fact that guanidinium chloride shows the same efficiency of 
destabilization as urea with sodium chloride in proteins that rely on salt bridges for their stability 
(Smith and Scholtz, 1996).  
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This is significant as Bluetongue virus VP7 contains more than double the alpha-helical content as 
beta-strand content (Grimes et al., 1995). It would appear, based on findings, that Bluetongue virus 
VP7’s stability is largely reliant on the stability of alpha-helical components found within the 
proteins as well as the intermolecular and intramolecular electrostatic interactions within the 
protein structure, which can then explain how guanidinium chloride, which is known to be able to 
interact with these components, is able to unfold the protein, whereas urea is unable to. 
Protein stability is particularly important in vaccine design as the conformation stability of a protein 
plays a large role in the immunogenic effectiveness of the antigens that the protein is presenting. 
This is significant for both conformational B cell epitopes and linear T and B cell epitopes as 
proteases can access the peptide backbone easily when the protein is unfolded (Scheiblhofer et al., 
2017). 
5. Conclusion.  
Full-length Bluetongue virus VP7 was expressed, using a pET28a plasmid and Escherichia coli 
expression system. It was then solubilized using a lower urea concentration with a freeze-thaw 
step, and purified using nickel-affinity chromatography to at least 95 % homogeneity. Bacterial 
expression resulted in predominantly insoluble Bluetongue virus VP7 expression under all 
conditions tested. Once solubilized from bacterial inclusion bodies, purified Bluetongue virus VP7 
was characterised and stability tested under a number of different conditions. Bluetongue virus 
VP7, when probed with far-UV CD and intrinsic fluorescence, was found to be stable until at least 
55 ˚C even when in 5 M urea, and its tertiary structure stability was increased with the addition of 
sodium chloride and a less cooperative unfolding was seen in the presence of glycerol, with a higher 
preservation of secondary and tertiary structure when heated to at least 90 ˚C. 
In the presence of 5 M urea, Bluetongue virus VP7 was seen to be predominantly a single 
monomeric form that has native-like secondary and a folded tertiary structure. There was little 
secondary or tertiary structure change seen even in 8 M urea. When urea was removed, protein 
precipitation was seen as the protein molecules grouped to form larger oligomers or aggregates. It 
can, therefore, be seen that urea is able to prevent protein molecules from forming oligomers or 
aggregates, but is ineffective at unfolding the structure of the protein.  
Guanidinium chloride’s ability to unfold Bluetongue virus VP7 where urea was unable to, suggests 
that the alpha-helical structures found within Bluetongue virus VP7, as well as intermolecular and 
intramolecular electrostatic forces,  play a large role in maintaining the stability of the Bluetongue 
virus VP7’s structure.  
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Glycerol and sodium chloride were able to increase preservation of protein structure by 
preferential hydration, which results in a more compact protected protein structure. Significantly, 
for further studies, the secondary and tertiary structure of Bluetongue virus VP7 in urea and 
glycerol appeared to be similar when probed with far-UV CD and fluorescence.  
Currently, the vaccines beings used have several downfalls, including non-cross neutralisation 
between serotypes, the inability to distinguish vaccinated animals from infected animals and 
genomic re-assortment occurring in cocktail attenuated vaccine administration. As there are no 
antivirals currently available and vaccines are expensive and often ineffective, an economically 
viable and fully protective vaccine is needed. The significance of Bluetongue virus VP7’s stability 
and high conservation across serotypes, along with its ability to induce a T-cell immune response, 
and the fact that regions on Bluetongue virus VP7 have been found to be accessible to host  
antibodies, makes it a viable candidate to be part of a recombinant protein vaccine against 
Bluetongue virus. 
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